Attention Functions in Children with Pediatric Chronic Kidney Disease by Duquette, Peter J.
 ATTENTION FUNCTIONS IN CHILDREN WITH PEDIATRIC CHRONIC KIDNEY 
DISEASE 
 
 
 
 
Peter J. Duquette 
 
 
 
 
A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill 
in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the 
School of Education (School Psychology). 
 
 
 
 
Chapel Hill 
2007 
 
 
 
 
 
 
 
 
 
 
Approved by: 
 
Committee Chair: Rune J. Simeonsson, Ph.D. 
 
Advisor: Stephen R. Hooper, Ph.D. 
 
Reader: Debbie S. Gipson, M.D. 
 
Reader: Samuel Song, Ph.D. 
 
Reader: Barbara H. Wasik, Ph.D. 
 ii 
© 2007 
Peter J. Duquette 
ALL RIGHTS RESERVED 
 iii 
ABSTRACT 
 
Peter Duquette: Attention Functions in Children with Pediatric Chronic Kidney Disease 
(Under the direction of Dr. Rune Simeonsson and Dr. Stephen Hooper) 
 
Children with chronic kidney disease (CKD) can evidence a variety of general 
and specific neurocognitive deficits, but little is known regarding the effects of pediatric 
CKD on specific domains of attention.  Using a variety of measures tapping specific 
domains (e.g., Focus/Execute, Sustain, Stability, Shift, Encode), the current study 
compared attention outcomes for school-age children with CKD to those of a typically-
developing control group. 
 The study addressed the following research questions: 1) Do specific domains of 
attention in children and adolescents with CKD differ significantly from those measured 
in typically-developing children and adolescents?  2) Do pediatric patients with CKD 
differ significantly from typically-developing children in their observed proportion of 
attention problems?  3) What functional- (e.g., recent school absences, IQ), family- (e.g., 
socioeconomic status), and disease-related (e.g., disease severity, age of onset, duration 
of disease) characteristics predict attention domain scores? 
Significant differences on group means were revealed between the CKD (n = 30) 
and control (n = 41) groups on the Focus/Execute, Sustain, Stability, and Encode 
attention domains; no group differences were evident on the Shift domain.  The CKD 
group also had a larger proportion of children with attention domain scores one standard 
deviation or more below the mean on the Shift and Encode domains.  The CKD and 
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control groups did not differ with respect to the proportion of scores falling one standard 
deviation or more below the mean on the Focus/Execute, Sustain, or Shift domains.  
Correlational data indicated that IQ scores and socioeconomic status were positively 
correlated with all five attention domains, while disease severity was negatively 
correlated with the attention domains.  Exploratory regression analyses indicated that IQ 
scores were a significant predictor of the Stability and Encode attention domains.  No 
predictors emerged for the Focus/Execute, Sustain, or Shift attention domains. 
In exploratory analyses with a subdivided CKD group, the end-stage renal disease 
(ESRD, i.e., kidney failure) group was found to have a higher proportion of attention 
scores one standard deviation or more below the mean on the Focus/Execute, Sustain, 
and Stability domains.  Exploratory univariate comparisons of children with ESRD 
versus those with mild/moderate CKD further suggested a potential effect of disease 
severity on attention. 
 Findings suggested that children with CKD may be vulnerable to subtle, specific 
deficits in domains of attention relative to their typically-developing peers.  Results also 
suggested that this finding of specific attention problems may be particularly relevant for 
children with more severe levels of CKD.  Facets of the current study, such as small 
sample size and other limitations, precluded broad generalizations of these findings to the 
pediatric CKD population as a whole.  Future research should utilize regression analyses 
to develop a model of risk using predictor variables when screening for neurocognitive 
deficits.  Using larger sample sizes and longitudinal analyses in future research may help 
to distinguish subtle attention problems in this population.  Limitations and suggestions 
for future research are discussed. 
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 CHAPTER I 
INTRODUCTION 
Overview 
Chronic Kidney Disease 
Chronic kidney disease (CKD) is a progressive deterioration of kidney function 
that cannot be reversed, and ultimately hinders the body’s ability to eliminate harmful 
toxins and waste products.  Criteria for CKD encompasses kidney function below 
approximately 75% of normal, and extends down to include individuals with little to no 
native function who are dependent on dialysis or a kidney transplant.  The National 
Kidney Foundation (NKF) through the Kidney Disease Outcomes Quality Initiative 
(KDOQI; NKF, 2002) has set forth guidelines that classify CKD into five stages of 
severity based on a measure called the estimated glomerular filtration rate (eGFR) as 
calculated by the Schwartz formula (Schwartz, Haycock, Edelmann, & Spitzer, 1976).  
This calculation provides an estimate of CKD severity based on how well an individual’s 
kidneys are filtering waste products within the body.  KDOQI represents an effort to 
improve patient outcomes through the development of clinical practice guidelines, by 
defining CKD according to the presence or absence of markers of kidney damage and the 
level of kidney function (eGFR), irrespective of the type of kidney disease or specific 
diagnosis.  The two independent criteria for CKD include the following: 1) Kidney 
damage for at least 3 months as defined by structural or functional abnormalities of the 
kidney, with or without decreased eGFR, manifested through either pathological 
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abnormalities or markers of kidney damage (e.g., blood or urine composition 
abnormalities, or abnormalities found in imaging tests); or 2) An eGFR less than 60 
mL/min/1.73m2 for at least 3 months, with or without kidney damage. 
An individual’s eGFR is the most informative index of kidney function in terms 
of health and disease.  Normal ranges for eGFR vary based on age, sex, body size, and 
serum creatinine levels in the blood.  Among individuals with CKD, the stage of severity 
is defined based on the level of kidney function using eGFR, with the higher CKD stages 
representing lower GFR levels (see Table 1).   
Table 1. 
KDOQI guidelines for stages of CKD. 
Stage Description eGFR (mL/min/1.73 m2) 
1 Kidney damage with normal or increased GFR > 90 
2 Kidney damage with mild decrease in GFR 60 – 89 
3 Moderate decrease in GFR 30 – 59 
4 Severe decrease in GFR 15 – 29 
5 Kidney failure < 15 (or dialysis) 
 
Stage 1 of CKD represents patients with kidney damage who have normal or 
elevated eGFR levels (> 90 mL/min/1.73m2).  Stages 2-4 correspond to patients with 
CKD who are treated with conservative therapies, and are often referred to as having 
chronic renal insufficiency (CRI).  Stage 2 includes patients with kidney damage and a 
mild decrease in eGFR levels (60-89 mL/min/1.73m2).  Stage 3 includes patients with 
kidney damage and a moderate decrease in eGFR levels (30-59 mL/min/1.73m2), while 
Stage 4 includes patients with kidney damage and severe/significant decreases in eGFR 
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level (15-29 mL/min/1.73m2).  Patients with end-stage renal disease (ESRD) encompass 
Stage 5 of CKD, which is defined as dialysis or transplant dependence or an estimated 
glomerular filtration rate (eGFR) < 15 mL/min/1.73m2. 
The term CKD is used to describe the full spectrum of kidney dysfunction, 
including individuals with CRI (also referred to as mild, moderate, or severe CKD) and 
ESRD (also referred to as kidney failure).  In contrast to adults, for whom the main 
causes of CKD are diabetes and high blood pressure, the most common causes of CKD in 
children are congenital abnormalities, including obstructive uropathy, renal dysplasia, 
reflux nephropathy, and focal segmental glomerulosclerosis (NKF, 2002; U.S. Renal 
Data System, 2005). 
CKD is a major public health problem, with a prevalence rate of ESRD in the 
United States of about 82.2 per million for individuals age birth to 19 years, and has been 
linked to poor health outcomes and high medical expenditures (U.S. Renal Data System, 
2005).  Recent improvements in dialysis regimens, transplantation procedures, nutritional 
support, and pharmacological management of comorbid anemia and hypertension have 
increased the survival rate for children with CKD to over 95% annually (Ferris, Gipson, 
Kimmel, & Eggers, 2006; Gipson, Wetherington, Duquette, & Hooper, 2004; Neu, Ho, 
McDonald, & Warady, 2002; Seikaly, Ho, Emmett, Fine, & Tejani, 2003; Smith, Ho, & 
McDonald, 2002; U.S. Renal Data System, 2005).  Despite documented improvements in 
medical care and increased rates of patient survival in pediatric CKD, however, the 
literature continues to identify neurodevelopmental concerns in children associated with 
this chronic illness, particularly for children who progress to ESRD and are dialysis- or 
transplant-dependent (Bawden et al., 2004; Brouhard et al., 2000; Crocker et al., 2002; 
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Davis, Chang, & Nevins, 1990; Duquette, Hooper, Wetherington, Jenkins, & Gipson, 
2007; Elzouki, Carroll, Butinar, & Moosa, 1994; Fennell, Fennell, Carter, Mings, & 
Klausner, 1990a; Fennell et al., 1990b; Gipson, Wetherington, Duquette, & Hooper, 
2004; Gipson et al., 2006; Groothoff, 2005; Hulstijn-Dirkmaat, Damhuis, Jetten, Koster, 
& Schroder, 1995; Lawry, Brouhard, & Cunningham, 1994; Ledermann et al., 2000; 
Mendley & Zelko, 1999; Qvist et al., 2002; Slickers, Duquette, Hooper, & Gipson, 2007; 
Warady, Belden, & Kohaut, 1999). 
Previous Research 
Neurodevelopment in Infants with CKD 
Early research in the field heightened concerns regarding neurodevelopmental 
delays for infants and preschool children with CKD (McGraw & Haka-Ikse, 1985; 
Polinsky, Kaiser, Stover, Frankenfield, & Baluarte, 1987; Rotundo et al., 1982; Warady, 
2002).  This literature indicated rather poor developmental outcomes for children with 
CKD during infancy, with the incidence of developmental delays estimated between 60-
85% (Bale, Siegler, & Bray, 1980; Baluarte, Gruskin, Hiner, Foley, & Grover, 1977; Bird 
& Semmler, 1986; Bock et al., 1989; McGraw & Haka-Ikse, 1985; Polinsky et al., 1987; 
Rotundo et al., 1982; So et al., 1987, Warady, 2002).  Developmental delays in infants 
and preschool children with CKD have been linked to a number of negative outcomes in 
the literature, including neurological conditions (e.g., microcephaly, seizures), mental 
retardation, reduced growth rates, impaired hemispheric maturation, and abnormal 
electrophysiological findings (Bock et al., 1989; Kari, Gonzalez, Ledermann, Shaw, & 
Rees, 2000; McGraw & Haka-Ikse, 1985; Polinsky et al., 1987; Rotundo et al., 1982; So 
et al., 1987; Van Dyck & Proesmans, 2001). 
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More recent research has suggested that severe neurodevelopmental problems 
may be less common than previously estimated for infants and preschool children with 
CKD (Duquette et al., in press; Elzouki et al., 1994; Geary & Haka-Ikse, 1989; Madden, 
Ledermann, Guerrero-Blanco, Bruce, & Trompeter, 2003; Warady, 2002; Warady et al., 
1999).  Current estimates suggest that neurodevelopmental delays, broadly defined, are 
evident in approximately one-fourth of young children with CKD (Gipson et al., 2004).  
The increase in positive findings outcomes reported in the literature with regards to early 
neurodevelopment in CKD has been correlated with several recent trends in treatment, 
including use of transplantation at earlier ages, increased protein and caloric intake 
through advanced nutritional support, and the elimination of aluminum-containing 
phosphate binders and improved water purification during dialysis (Elzouki et al., 1994; 
Geary & Haka-Ikse, 1989; Ledermann et al., 2000; NKF, 2001; Qvist et al., 2002; 
Warady, 2002; Warady et al., 1999). 
Neurocognition in School-Age Children with CKD 
For older children with CKD, more formal measures of intelligence (IQ) have 
been obtained, with the general consensus being that school-age children with CKD show 
a normal distribution of IQ scores that is shifted slightly downward compared with the 
normal population (Bawden et al., 2004; Brouhard et al., 2000; Duquette et al., 2007; 
Gipson et al., 2006; Hulstijn-Dirkmaat et al., 1995; Lawry et al., 1994; Madden et al., 
2003; Mendley & Zelko, 1999; Qvist et al., 2002).  Cross-sectional case-control studies 
on children with CKD have reflected this trend.  Brouhard and colleagues (2000) reported 
significantly lower IQ scores for children with ESRD, including both dialysis and 
transplant groups, when compared to a sibling control group.  Bawden and colleagues 
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(2004) also found significant differences in IQ between children with ESRD versus a 
typically-developing, matched control group, with children in the ESRD group having 
lower Verbal IQ, Performance IQ, and Full Scale IQ scores.  Warady and colleagues 
(1999) also reported that that 21% of their sample of school-age children with ESRD 
from infancy had Full Scale IQ scores below the average range (i.e., defined as age-based 
Standard Scores 90 – 109).  Among this sample, only 72% of participants achieved at 
least average Verbal IQ scores, while only 56% had average Nonverbal IQ scores 
(Warady et al., 1999). 
Comparisons of Full Scale IQ scores within groups of children with CKD have 
produced variable results.  Lawry and colleagues (1994) evaluated transplanted children 
(n = 13) and dialysis-dependent children (n = 11) in a cross-sectional study, and found a 
higher mean IQ in the transplant group, although both groups fell largely within the 
average range. Similarly, Crocker and colleagues (2002) found no differences between 
children with ESRD from birth (congenital) versus children with acquired ESRD.  
Conversely, in a cross-sectional study, no differences were reported for the intellectual 
functioning of transplant versus dialysis-dependent groups (Brouhard et al., 2000). 
Findings in the literature also point to significant concerns for the 
neuropsychological integrity of children with CKD across specific domains of 
functioning.  Contemporary studies on attention, memory, and executive functions with 
pediatric CKD samples suggest that these areas of neurodevelopmental concern should be 
monitored continually over time (Fennell et al., 1990; Gipson et al., 2006; Mendley & 
Zelko, 1999; Qvist et al., 2002).  Findings suggest the possibility that the progression of 
CKD may disrupt attention, memory, and executive functions beyond the generalized 
 7 
effects of lower IQ and lower socioeconomic status (SES; Gipson et al., 2006).  These 
neuropsychological deficits associated with CKD may subsequently impact a child’s life 
course by limiting the degree of educational attainment and future vocational choices 
available to this population (Groothoff, 2005). 
Factors Influencing Neurocognitive Problems in CKD 
A number of factors have been proposed to explain the presence of 
neurocognitive dysfunction in the pediatric CKD population.  The age of onset and 
duration of illness (Crocker et al., 2002; Davis et al., 1990; Elzouki et al., 1994; Hulstijn-
Dirkmaat et al., 1995; Lawry et al., 1994; Madden et al., 2003), the modality of renal 
replacement therapy (Brouhard et al., 2000; Hulstijn-Dirkmaat et al., 1995; Qvist et al., 
2002; Warady et al., 1999), and complications of CKD treatment including aluminum 
toxicity, malnutrition, anemia, and hypertension (Gorman, 1995; Grantham-McGregor, 
1995; Halterman,  Kaczorowski, Aligne, Auinger, & Szilagyi, 2001; Lande, 
Kaczorowski, Auinger, Schwartz, & Weitzman, 2003; Levitsky & Strupp, 1995; Marsh et 
al., 1991), all may contribute to these deficits. 
Aluminum neurotoxicity is the presence of measurable amounts of aluminum in 
the brain resulting from increased aluminum levels in the blood and subsequent passage 
through the blood-brain barrier.  For patients with CKD, aluminum levels were at one 
time elevated due to impure dialysis water purification during hemodialysis, in which the 
patient’s blood is filtered through an external machine to remove toxins and waste 
products to provide clean blood to the body.  Research into this treatment method, in 
addition to the use of aluminum-containing phosphate binders, established a clear 
connection with neurocognitive dysfunction (Andreoli, Bergstein, & Sherrard, 1984; 
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Sedman, Miller, Warady, Lum, & Alfrey, 1984; Sedman, Wilkening, Warady, Lum, & 
Alfrey, 1984).  The neurocognitive effects of aluminum-induced neurotoxicity included 
seizures, speech disorders, dementia, and a slow pattern on EEG (Alfrey, LeGendre, & 
Kaehny, 1976; Andreoli et al., 1984).  The effects of aluminum intoxication from long-
term hemodialysis in adults with ESRD also were associated with severe cognitive 
deterioration and death (Alfrey, 1978; Lederman & Henry, 1978).  This was a key finding 
for the field in that it encouraged modifications to the dialysis treatment regimen and 
highlighted a confounding factor in the relationship between CKD and neurocognitive 
integrity.  By the 1990s, the use of improved dialysis water purification techniques and 
avoidance of aluminum-containing medications reduced the confounding factor of 
aluminum intoxication during treatment processes (Gipson et al., 2004), and is therefore 
no longer empirically relevant for contemporary studies of pediatric patients with CKD. 
Malnutrition is another significant issue for patients with CKD that can 
potentially lead to neurocognitive deficits (Conley, 1987; NKF, 2001; Warady, 2002; 
Winick, 1969).  Malnutrition is important for patients with CKD due to the need for low 
intake of protein, phosphorus, and sodium in this population because the kidneys do not 
filter these materials well with suboptimal function (NKF, 2001).  Protein is converted in 
the body into a waste product called urea once it is fully consumed for muscle growth and 
tissue repair, and suboptimal function of the kidneys causes urea to build up in the body 
and leads to negative cognitive effects (Gipson et al., 2004).  Furthermore, high levels of 
phosphorus in the body lead to decreased calcium levels and cause bones to break more 
easily (NKF, 2001).  Efforts to control kidney function through dietary restrictions can 
lead to malnutrition if patients do not receive adequate levels of necessary minerals and 
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vitamins over an extended period of time; however, most inter-disciplinary teams that 
treat children with CKD include nutritionists for this exact reason (NKF, 2001).  In this 
sense, malnutrition, much like aluminum neurotoxicity, also poses less of a threat 
currently to neurocognitive function in the CKD population due to improvements in 
treating this co-occurring aspect of CKD.  Generally speaking, the impact of malnutrition 
on cognitive function has been well-documented broadly in the literature (Grantham-
McGregor, 1995), with evidence of generalized cognitive deficits manifested as low IQ 
scores, academic underachievement, and increased behavioral problems.  These issues 
persist into adolescence, but do improve significantly with appropriate interventions, 
although the exact mechanism linking malnutrition to neurocognitive deficits has not 
been established to this point (Grantham-McGregor, 1995). 
Anemia and hypertension are issues that continue to this day to have important 
implications for neurocognitive function in children with CKD.  Low red blood cell 
counts and decreased hemoglobin levels have been extensively associated with 
neurocognitive dysfunction in the pediatric sickle cell disease population (Kral, Brown, 
& Hynd, 2001; Lemanek, Ranalli, Green, Biega, & Lupia, 2003; Noll et al., 2001).  It 
serves to reason then that anemia secondary to CKD could also affect neurocognitive 
function, and the literature has backed this claim.  Erythropoietin (also referred to as 
epogen and EPO) was introduced into standard practice in the early 1990s, resulting in 
improved anemia management in the CKD population (Gipson et al., 2004).  In adults 
with ESRD, a diminution of anemia-related EEG abnormalities and cognitive deficits 
were subsequently reported (Marsh et al., 1991; Pickett, Theberge, Brown, Schweitzer, & 
Nissenson, 1999; Sagales, Gimeno, Planella, Raguer, & Bartolome, 1993). 
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Similar concerns are evident with regards to neurocognitive function and 
hypertension.  In addition to the wealth of literature suggesting neurocognitive 
dysfunction in elderly individuals with hypertension, a population-based study of 
children with hypertension has shown that these children have difficulties with tasks 
requiring memory, attention, and concentration (Lande et al., 2003).  For patients with 
hypertension and CKD, additional dietary concerns specific to the need for low sodium 
intake presents another challenge to these individuals. 
Current Study 
 The current study examined attention in children and adolescents with chronic 
kidney disease (CKD) relative to a group of typically-developing peers.  Data were 
examined from an existing database collected on a sample of children in North Carolina 
who received medical treatment for CKD at a local university teaching hospital, and a 
comparison group that was recruited from within the catchment area of that same 
hospital.  Data included outcome measures tapping into components of attention obtained 
via standardized neuropsychological testing administered by a trained examiner under the 
supervision of a clinical neuropsychologist.  Demographic and other related variables 
collected via informal questionnaire were also examined. 
Statement of Purpose 
 Attention is a key component of developmental success in the academic, 
vocational, and interpersonal domains.  Problems with lack of sustained focus, 
inconsistent concentration, limited storage of working memory, and/or lack of inhibitory 
controls can potentially have negative impacts on multiple areas of functioning.  
Furthermore, such problems can persist throughout childhood and adolescence and into 
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adulthood, thereby increasing the likelihood that related problems could occur.  For these 
reasons, and given the research suggesting that CKD may lead to negative neurocognitive 
outcomes during childhood and adolescence, it is important that the specific domains of 
attention of pediatric patients with CKD be examined carefully. 
 The current study sought to add valuable information to an area where previous 
research is lacking.  By investigating the integrity of attention in children with CKD in 
relation to their typically-developing peers, it was expected that critical information 
would be gained regarding the psychoeducational and treatment needs of this patient 
sample.  With regard to specific neuropsychological domains, documented problems with 
attention have been associated with the degree to which children with CKD retrieve 
acquired information and build upon areas of hierarchical learning (Fennell et al., 1990b; 
Qvist et al., 2002).  These studies have been conducted in a broader examination of the 
entire spectrum of neurocognitive functions, without using an a priori model underlying 
the conceptualization of attention.  Understanding the integrity of specific attention 
domains in these patients could benefit the CKD population as a whole by increasing 
awareness for the need of psychoeducational support services if CKD is found to 
negatively impact attention and academic performance in children (Duquette et al., 2007), 
while also intervening at earlier time points to lessen the morbidity for medical, 
educational and future employment outcomes (Groothoff, 2005). 
Research Questions and Hypotheses 
Although recent medical advancements have resulted in increased survival rates 
for children with CKD, concerns related to neurodevelopmental outcomes persist for this 
pediatric population.  To date, no studies have specifically examined attention in children 
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with CKD using a research-based neuropsychological model of attention, and only a 
handful of studies have examined executive functions in children with CKD.  Using the 
neuropsychological model of attention pioneered by Mirsky and colleagues (Mirsky, 
1987, 1989, 1996; Mirsky et al., 1991, 1995a, 1995b, 1999) as an underlying basis, this 
study compared specific attention domains of children with CKD to those of a matched 
control group using a cross-sectional retrospective case-control design. This study 
addresses the following research questions and hypotheses: 
 
1) Do specific domains of attention in children and adolescents with CKD differ 
significantly from those measured in typically-developing children and adolescents?  
Children with CKD may exhibit attention problems when compared to a matched control 
group.  Taking the previous literature to date into consideration (Fennell et al., 1990a, 
1990b; Gipson et al., 2006; Qvist et al., 2002; Yount, Jacobs, Bustamante, & Brickman, 
1998) in the context of Mirsky’s model of attention (1987, 1989, 1996; Mirsky et al., 
1991, 1995a, 1995b, 1999), it was hypothesized that the CKD group would score lower 
than the control group on several specific attention domains (Focus/Execute, Sustain, and 
Encode).  It was also hypothesized that the CKD group would exhibit similar 
performance to the control group on several other attention domains (Stability, Shift). 
 
2) Do pediatric patients with CKD differ significantly from typically-developing 
children in their observed proportion of attention problems?  Specifically, does a 
higher proportion of pediatric patients with CKD evidence difficulties with attention one 
standard deviation or more below the mean (defined as an age-based Standard Score (SS) 
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< 85)?  It was hypothesized that a higher proportion of children in the CKD group would 
demonstrate attention problems (SS < 85) relative to the control group within several 
specific attention domains (Focus/Execute, Sustain, and Encode).  It was also 
hypothesized that children in the CKD group would demonstrate similar proportions of 
problems on the Stability and Shift attention domains. 
 
3) What functional- (e.g., recent school absences, IQ), family- (e.g., SES), and 
disease-related (e.g., disease severity, age of onset, duration of disease) variables 
predict attention domain scores?  It was hypothesized that lower IQ scores, higher 
numbers of school absences, lower SES, earlier age of CKD onset, longer duration of 
CKD, more severe levels of CKD (lower eGFR calculations), and co-morbid diagnoses of 
anemia or hypertension would be associated with lower scores on all attention domains 
(Focus/Execute, Sustain, Stability, Shift, Encode).  Furthermore, it was hypothesized that 
IQ scores, SES, and CKD severity (eGFR) would be significant predictors of all five 
attention domains within the proposed model of attention.
 CHAPTER II 
LITERATURE REVIEW 
Introduction 
Despite a number of studies examining the medical and neurodevelopmental 
outcomes related to chronic kidney disease (CKD), existing literature has not adequately 
addressed the integrity of attention in children and adolescents with CKD.  Literature on 
attention functioning secondary to pediatric CKD reveals mixed findings (Fennell et al., 
1990a, 1990b; Gipson et al., 2006; Mendley & Zelko, 1999; Qvist et al., 2002).  Findings 
from this research are not consistent, and these studies do not utilize similar methodology 
or theoretical bases to examine attention in the pediatric CKD population. 
To address the need for research evidence regarding the integrity of attention 
functioning in pediatric patients with CKD, the goals of the current study are to provide a 
basis to 1) compare performance within specific domains of attention in children and 
adolescents with CKD to that of a group of their healthy peers; 2) compare the 
frequency of attention dysfunction between these groups; and 3) determine what 
functional-, family-, and disease-specific variables are associated with and predict 
attention scores in children and adolescents with CKD.  The following chapter 
provides a review of recent literature and an empirically-based rationale for conducting 
the study.  Topics covered include a review of previously investigated models of 
attention, attention outcomes in the CKD population, attention outcomes in other 
pediatric medical populations, and medical variables affecting neurocognitive processes. 
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Models of Attention 
Problems with attention have been linked to a number of disorders and 
syndromes, including type 1 diabetes (Northam et al., 2001; Rovet & Alvarez, 1997), 
spina bifida (Dennis, Landry, Barnes, & Fletcher, 2006), sickle cell disease (Kral et al., 
2001; Lemanek et al., 2003; Noll et al., 2001), pediatric HIV/AIDS (Armstrong, Willen, 
and Sorgen, 2003; Bisiacchi, Suppiej, & Laverda, 2000; Brouwers, Belman, & Epstein, 
1994), pediatric cancer (Vannatta & Gerhardt, 2003), seizure disorder (Cohen, Malloy, & 
Jenkins, 1999), traumatic brain injury (Bigler, 2003), postnatal lead exposure (Chiodo, 
Jacobson, & Jacobson, 2004), post-traumatic stress disorder (Vasterling, Brailey, 
Constans, & Sutker, 1998), and congenital hypothyroidism (Rovet & Hepworth, 2001).  
However, the disorder most defined by significant attention problems is obviously 
attention-deficit/hyperactivity disorder (ADHD), with a prevalence rate estimated 
between 3-10% of school-age children nationwide (Barkley, 2003). The parents and 
teachers of children with attention problems face many frustrations which have given 
way to large commercial interests in this area over the last several decades, including 
numerous books, brochures, tools used to assess and treat these symptoms, and many 
pharmacological interventions.  Scientific and theoretical contributions have been 
numerous, and are briefly reviewed next. 
Multiple views on models of attention have been posited over the years, and 
variations among the models have been evident depending on the discipline supplying the 
research (e.g., psychiatry in clinical settings, research on cognitive processes, and 
neuropsychology) and over time.  Early models viewed attention from the perspective of 
perceptual information processing (Broadbent, 1953; 1957) in which attention played the 
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role of a filtration system that attended to relevant information based on the intensity, 
importance, and novelty of the stimuli.  Arousal theory is another model of attention 
popularized in the mid-20th century, which linked alertness to effortful function through 
the input of sensory stimuli (Pribram & McGuiness, 1975; Samuels, 1959).  The 
incorporation of fluid cognitive abilities, such as concentration, flexibility, and 
processing speed (Stankov, 1988) has also been suggested to be salient in the discussion 
of attention.  These early models provided important frameworks for conceptualizing 
attention as a multi-step or multi-component process, but empirically measuring the 
filtration of relevant information or degree of alertness under conditions that could be 
generalized to the real world became difficult.  Additionally, the need to link specific 
brain regions to functional abilities also became increasingly important with the increased 
availability of neuroimaging and as cognitive neuroscience became more prevalent 
during the late 1970s and early 1980s. 
Posner (Posner, 1980; Posner & Petersen, 1990) has posited a model of visual 
attention that utilizes approaches from cognitive neuroscience and described the process 
of orienting, shifting, and controlling one’s attention.  Posner contends that attention can 
be deployed in one of two ways during any visual search, either under the overt control of 
the individual (e.g., “top-down” or endogenous attention) or covertly without control of 
the individual (e.g., “bottom-up” exogenous attention).  Endogenous attention is 
voluntary and effortful, whereas exogenous attention is rapid and automatically draws 
focus to a specific location.  Stimulus-driven control of attention also involves interaction 
between the bottom-up and top-down attentional control systems in Posner’s model 
(Posner, 1980).  Inhibitory mechanisms and visual priming/cuing also play a significant 
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role in Posner’s model with regards to shifting and returning attention to specific targets 
(Posner, 1980), with neural correlates being singled out in more recent examinations of 
the topic (Posner & Petersen, 1990).  Although this model of visual attention is an 
important contribution to the field, it is problematic to entirely dismiss the impact of 
auditory input when conceptualizing domains of attention, which could be an area of 
specific weakness for the pediatric CKD population.  Utilizing a model with expanded 
utility to include auditory vigilance and other attention subcomponents, such as 
stabilizing or encoding attention, could provide a comprehensive view. 
More recently, attention has been closely associated with executive function (EF) 
constructs and neuropsychological functioning to formulate a multifaceted approach.  EF 
constructs include such varied abilities as sustaining attention, controlling impulses, 
planning, organizing, maintaining a response set, and solving problems, with slight 
variations noted with each researcher (Cohen, 1993a, 1993b; Denckla, 1996).  Executive 
control also taps into a specific component of EF dealing with self-regulation, self-
direction, goal-directed behaviors, and response inhibition (Barkley, 2003; Cohen, 1993a, 
1993b; Denckla, 1996).  Various definitions of EF have been increasingly linked 
functionally to specific cortical structures and systems (Riccio, Reynolds, & Lowe, 
2001).  However, because attention and EF are such multifaceted but similar constructs, it 
is difficult to link specific individual neuropsychological behaviors of interest through 
one-to-one correspondence to specific neurological components or brain structures 
(Mirsky, Fantie, & Tatman, 1995a).  The various models of attention and EF, however, 
consistently implicate a complicated functional system involving interactions among 
cortical structures (frontal, prefrontal, parietal, and temporal), subcortical structures 
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(limbic system, basal ganglia, reticular activating system), and projections to/from the 
thalamus and frontal lobes (Cohen & O’Donnell, 1993; Luria, 1966; Riccio et al., 2001). 
Mirsky’s Model of Attention 
Allan F. Mirsky is one researcher that has contributed to the knowledge base on 
attention problems.  Mirsky and his colleagues (Mirsky, 1987, 1989, 1996; Mirsky, 
Anthony, Duncan, Ahearn, & Kellam, 1991; Mirsky et al., 1995a; Mirsky, Ingraham, & 
Kugelmass, 1995b; Mirsky, Pascualvaca, Duncan, & French, 1999) have posited a 
neuropsychological model to describe the elements of impaired attention.  The model 
hypothesizes that each element (including the ability to sustain, encode, focus, regulate, 
and shift attention) is supported by distinct cerebral regions, and can be assessed with 
specific neuropsychological tests.  This approach has demonstrated that attention is not a 
unitary brain process, but comprises a group of highly articulated functions. 
Contributions to the Model 
Mirsky’s model of attention was originally developed from a developmental-
evolutionary perspective that examined the brain as a “triune” structure (MacLean, 1990).  
This structural model analyzed the core processes of attention as a predominantly brain 
stem system that existed for millions of years and continues to exist in the brains of 
modern reptiles (Mirsky, 1987, 1989, 1996; Mirsky et al., 1991, 1995a, 1995b, 1999).  
The reptilian portion of the brain consists of the gray matter in the cerebrum, along with 
portions of the basal ganglia including the caudate, putamen, globus pallidus, and 
connections to the thalamus and pontine regions of the brain stem (Mirsky, 1987, 1989, 
1996; Mirsky et al., 1991, 1995a, 1995b, 1999).  This region is overlaid by the 
paleomammalian brain, which includes the limbic system of the brain (e.g., the 
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amygdala, hippocampus, cingulate gyrus).  Finally, the neomammalian brain is 
comprised of neocortical structures and thalamic connections.  Mirsky’s stance for 
supporting this developmental-evolutionary perspective is that MacLean (1990) has 
shown that the reptilian brain can support many behaviors that could be characterized as 
sustained or attentive, and newer cortical structures from an evolutionary standpoint 
provided the means for additional capacity for attentive behavior.  The capacity for visual 
attention in infants (Lansink & Richards, 1997; Lawson & Ruff, 2004) has been cited as 
reasoning that sustained attention can be supported prior to complete myelination of the 
neocortex, providing further evidence for this connection made by Mirsky. 
Another theoretical contribution to Mirsky’s model of attention came from 
research on the early development of the original continuous performance test (CPT; 
Rosvold, Mirsky, Sarason, Bransome, & Beck, 1956) and research on the study of 
epilepsy (Penfield & Jasper, 1954).  The CPT was a landmark assessment tool for the 
neuropsychological measurement of attention when it was pioneered in the mid-1950s, as 
it could differentiate between “brain-injured” and “non-brain-injured” groups among 
various samples including adults with normal intelligence, children with normal 
intelligence, and persons diagnosed with mental retardation (Rosvold et al., 1956).  
Further inquiry into the link between brain injury and impairments on the CPT suggested 
that damage to midline subcortical brain regions was most related to impairment in 
sustained attention on the CPT (Mirsky & Van Buren, 1965). 
Individuals who demonstrated the most accurate portrayal of this attention profile 
suffered from absence epilepsy, which was earlier referred to as centrencephalic epilepsy 
(Mirsky, 1987, 1989, 1996; Mirsky et al., 1991, 1995a, 1995b, 1999).  The term 
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“absence” was used for these patients because of their brief moments of unresponsiveness 
during which interruptions of attention occurred simultaneously as abnormal EEG 
patterns (Mirsky & Van Buren, 1965).  Earlier research by Penfield and Jasper (1954) 
indicated that the centrencephalic system was located at the level of the brain stem 
reticular formation and midline thalamus, and it served as a major organizational center 
devoted to consciousness, arousal, and attention (Lindsley, 1960; Penfield & Jasper, 
1954).  The centrencephalic disturbances associated with absence epilepsy were later 
designated as corticoreticular in nature because of the linkage between subcortical 
reticular disturbances in the brain stem region and their connections to cortical structures 
(Mirsky, 1987, 1989, 1996; Mirsky et al., 1991, 1995a, 1995b, 1999).  This line of 
reasoning was in keeping with the reptilian portion of MacLean’s (1990) “triune” brain, 
suggesting that individuals with disturbances in vigilance or sustained attention exhibited 
some pathological involvement of the corticoreticular system (Mirsky, 1987, 1989, 1996; 
Mirsky et al., 1991, 1995a, 1995b, 1999). 
In this sense, the predominant theme within current research suggesting that 
attention represents a complex set of highly coordinated processes in the brain concurred 
with the developmental-evolutionary and centrencephalic/corticoreticular perspectives of 
the brain’s structural involvement (Mirsky, 1987, 1989, 1996; Mirsky et al., 1991, 1995a, 
1995b, 1999).  This coordinated system of attention proposed connections among 
neocortical, limbic, and cerebral regions through centrencephalic/corticoreticular 
pathways to form the basic foundation of Mirsky’s model of attention (Mirsky, 1987, 
1989, 1996; Mirsky et al., 1991, 1995a, 1995b, 1999).  This view also followed with 
contemporary information-processing theories of attention that linked many different 
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mental operations to attention, including selectivity, focusing, sustained vigilance, 
switching attention, rehearsal, coding, and retrieval (Mirsky, 1996; Mirsky et al., 1999; 
Posner & Petersen, 1990; Shiffrin, 1988).  Mirsky and colleagues proposed a “restricted 
taxonomy of attentive functions” that was based on results from neuropsychological test 
data and subsequent factor analyses on over 600 subjects, most of whom had various 
disturbances of attention functions (Mirsky, 1996; Mirsky et al., 1999). 
Attention domains 
The restricted taxonomy of attention included five domains comprising 
focusing/executing, sustaining, stabilizing, shifting, and encoding behaviors, each of 
which tap specific attention functions, could be measured by various neuropsychological 
tests, and were linked to specific brain regions (Mirsky, 1987, 1989, 1996; Mirsky et al., 
1991, 1995a, 1995b, 1999).  This organization created a system of shared responsibility 
in which functional and structural specialization was not absolute, allowing some degree 
of substitution in the event of an injury (Mirsky, 1987, 1989, 1996; Mirsky et al., 1991, 
1995a, 1995b, 1999).  The five domains of Mirsky’s model are reviewed below. 
Focus/Execute.  The attention domain of Focus/Execute deals with the ability to 
concentrate attentional resources on a task, while screening out distracting stimuli usually 
under timed conditions (Mirsky, 1987, 1989, 1996; Mirsky et al., 1991, 1995a, 1995b, 
1999).  In their effort to isolate this domain, Mirsky and colleagues had difficulty 
separating this aspect of attention from executing, which refers to the task demand of 
rapid response (Mirsky, 1987, 1989, 1996; Mirsky et al., 1991, 1995a, 1995b, 1999).  
Tests used to measure this attention function include the Digit Symbol Substitution 
subtest from the Wechsler Adult Intelligence Scale – Revised (WAIS-R), the Stroop Test, 
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and the Trail Making test (Parts A & B) from the Halstead-Reitan Battery.  The function 
of focusing on environmental events involves the superior temporal cortex, inferior 
parietal cortex, and the corpus striatum regions of the brain, while the execution of 
responses involves the inferior parietal and corpus striatum regions (Mirsky, 1987, 1989, 
1996; Mirsky et al., 1991, 1995a, 1995b, 1999). 
Sustain.  The attention domain of Sustain deals with an individual’s ability to stay 
on-task for an extended period of time in a vigilant manner (Mirsky, 1987, 1989, 1996; 
Mirsky et al., 1991, 1995a, 1995b, 1999).  Variables that measure the number of correct 
targets an individual selects from various CPTs can tap into sustaining attention, 
including both visual and auditory stimuli.  Mirsky and colleagues (Mirsky, 1987, 1989, 
1996; Mirsky et al., 1991, 1995a, 1995b, 1999) have demonstrated that rostral midbrain 
structures, including the mesopontine reticular formation and midline/reticular thalamic 
nuclei, are associated with the ability to sustain attention. 
Stability.  Related to one’s capacity to sustain attention, the attention domain of 
Stability refers to the ability to maintain consistency within a predictable response pattern 
over time (Mirsky, 1987, 1989, 1996; Mirsky et al., 1991, 1995a, 1995b, 1999).  This can 
include measuring the variability of reaction time to target stimuli on CPTs, along with 
the variability of correct or incorrect response patterns among consecutive blocks of trials 
within an administration of the CPT (Mirsky, 1987, 1989, 1996; Mirsky et al., 1991, 
1995a, 1995b, 1999).  The stability function is said to be dependent upon several regions, 
including midline-thalamic and brain stem structures (Mirsky, 1987, 1989, 1996; Mirsky 
et al., 1991, 1995a, 1995b, 1999). 
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Shift.  The attention domain of Shift deals with the ability to move from one 
salient aspect of a stimulus to another in a flexible, efficient manner (Mirsky, 1987, 1989, 
1996; Mirsky et al., 1991, 1995a, 1995b, 1999).  The hallmark measure used to assess 
this attention domain is the Wisconsin Card Sorting Test (Mirsky, 1987, 1989, 1996; 
Mirsky et al., 1991, 1995a, 1995b, 1999), although other measures that tap into problem-
solving over varying trials, such as the Tower of London and Tower of Hanoi tasks, have 
also been used as measures of set-shifting in other studies (Gipson et al., 2006; Hooper, 
Swartz, Wakely, de Kruif, & Montgomery, 2002).  The brain regions purported to be 
involved with this function include the dorso-lateral prefrontal cortex, specifically the 
anterior cingulate gyrus (Mirsky, 1987, 1989, 1996; Mirsky et al., 1991, 1995a, 1995b, 
1999). 
Encode.  Mirsky and colleagues have consistently identified the attention domain 
of Encode, which involves a mnemonic capacity related to working memory that allows 
individuals to hold information briefly in their mind while performing a cognitive 
operation on this information (Mirsky, 1987, 1989, 1996; Mirsky et al., 1991, 1995a, 
1995b, 1999).  Various digit span subtests have been consistently used to measure this 
aspect of attention within Mirsky’s model.  The encoding function is maintained within 
brain regions associated with the limbic system, including the hippocampus and the 
amygdala (Mirsky, 1987, 1989, 1996; Mirsky et al., 1991, 1995a, 1995b, 1999). 
Considerations 
Despite the large amount of research backing the claims in this model of attention, 
there are certain factors to consider when one examines its place within the entirety of 
previous research of attention.  Within the larger scheme of things, the contribution of 
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Mirsky’s model of attention to the field does provide clarity to the available literature 
from a neuropsychological framework.  There exists a dearth of studies that have linked 
functional domains to various structural regions within a model of attention using test 
data to support this claim; therefore, Mirsky’s model is unique and convincing in this 
respect.  However, the study of attention, memory, and EF has become increasingly 
complex and muddied throughout the years because of the varying conceptual and 
theoretical bases used by different researchers (Lyon, 1996; Morris, 1996).  The fuzzy 
boundaries have created varying constructs and measurement models among researchers, 
and a measure used in one study for testing attention may also be used occasionally in 
another study to test EF (Morris, 1996).  This theoretical overlap has been addressed 
previously (Gibson & Rader, 1979; Morris, 1996), and researchers have struggled with 
separating these three functions to adequately address construct validity (Fletcher et al., 
1996).  For instance, domains utilized in Mirsky’s model of attention have some degree 
of overlap with models of executive functions (Daigneault, Braun, & Whitaker, 1992; 
Denckla, 1996).  Therefore, it is important to consider this overlap among various models 
when studying attention, in addition to the specific contributions that each model 
provides on its own accord. 
Mirsky’s model of attention is utilized in the current study as a means to measure 
attention in children with CKD for a number of reasons.  The historical context of this 
model as it relates to previous research on individuals with epilepsy, in addition to the 
contribution from the development of the original CPT, both provide empirical bases to 
support its connection to developmental-evolutionary and multi-component information 
processing perspectives.  Furthermore, Mirsky’s use of a factor structure to generate this 
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model appears to lend additional strength to its utility with a pediatric CKD population 
that most executive function models have not utilized.  In short, Mirsky’s model 
incorporates strengths from the various models of attention proposed to date, while 
simultaneously providing a broad framework to conceptualize the multidimensional 
construct of attention. 
Previous Applications of Mirsky’s Model of Attention 
 Several studies have utilized Mirsky’s (1987, 1989, 1996; Mirsky et al., 1991, 
1995a, 1995b, 1999) neuropsychological model to characterize the specific domains of 
attention observed in various populations.  Researchers have recognized Mirsky’s 
contribution to the attention literature by speaking of their attention battery as aligning 
with the multiple domains of this model, but relatively few studies actually assess every 
domain with the suggested tests or validated analogs.  The populations examined in these 
comprehensive studies are quite varied, with insight provided on specific attention 
domains within Mirsky’s model for individuals with CKD, post-traumatic stress disorder 
(PTSD), autism, congenital hypothyroidism, prenatal teratogen exposure, and postnatal 
lead exposure.  Examining these studies can provide valuable insight as to how specific 
attention domains in children with CKD may be portrayed through Mirsky’s model. 
 Chronic Kidney Disease.  Yount and colleagues (1998) utilized the original model 
posited by Mirsky (1987) as a framework to examine specific attention domains in adults 
with CKD.  These researchers examined data from 554 adults with ESRD in an effort to 
identify potential psychosocial and biomedical predictor variables (Yount et al., 1998).  
Results suggested three underlying factors including sustained attention, focused 
attention, and memory recall (Yount et al., 1998).  Sustained attention was comprised of 
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CPT data, including Total Correct, Mean Response Time, and Variance scores.  Focused 
attention was comprised of data from the Stroop Color-Word test, Trail Making Test Part 
B, and Digit Span Forward.  Memory recall was comprised of data from total and delayed 
free recall scores.  Sustained attention and memory recall were found to only be 
associated with gender.  Focused attention was found to be most strongly associated with 
psychosocial and biomedical variables, with younger age, less severe CKD, higher 
education levels, and higher vocabulary scores being positively correlated, and use of 
hemodialysis being negatively correlated, with better performance in this domain.  These 
findings were consistent with previous findings in adult CKD samples (Pliskin, Yurk, Ho, 
& Umans, 1996; Wolcott et al., 1988).  The results from this study also provide empirical 
evidence indicating inconsistencies among the various domains of attention in a sample 
of adults with CKD, which suggests possible generalization of this profile to children 
with CKD. 
Post-traumatic Stress Disorder.  The available literature has also produced mixed 
findings regarding the potential for neuropsychological dysfunction to result from 
extreme psychological stress and emotional dysregulation, although more consistent 
negative outcomes in the areas of attention, memory, learning, and organizational 
processes have been reported for prisoner of war survivors.  However, the co-occurrence 
of biological and psychological insults for these individuals makes it difficult to fully 
characterize neuropsychological dysfunction in this population as only due to 
psychological stress (Vasterling et al., 1998).  To this end, adults with PTSD who served 
in the first Persian Gulf War were assessed on measures of attention and memory on a 
battery of tests designed to load onto analogous constructs from Mirsky’s model of 
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attention (Vasterling et al., 1998).  Less proficient attention performance was noted based 
on scores on the WAIS-R Arithmetic and Commissions portion of the CPT, suggesting 
difficulties with encoding abilities and sustained attention when compared to veterans 
without PTSD (Vasterling et al., 1998).  This pattern of results suggested a tendency 
towards response disinhibition for individuals with PTSD that have consistent re-
experiencing episodes. 
 Autism.  For children with autism, attention is a difficult construct to measure due 
to the confounding influence of their inability to function socially.  Using Mirsky’s model 
of attention, a research team attempted to quantify the degree and type of attention 
dysfunction in a sample of 23 children with autism.  Contrary to findings in the adult 
PTSD literature, school-age children with autism exhibited intact focus and sustained 
attention capacities based on performance similar to the control groups on digit 
cancellation and CPT tasks (Pascualvaca, Fantie, Papageorgiou, & Mirsky, 1998).  
However, there was considerable evidence suggesting the possibility of difficulties with 
disengaging on shifting tasks (e.g., the Wisconsin Card Sorting Task – WCST).  
However, using two novel computerized measures of shifting attention, the researchers 
found that children with autism performed similarly to controls.  These findings lend 
evidence to the available literature indicating that individuals with autism have adequate 
attention capacities that are consistent with repetitive behaviors despite a tendency to not 
disengage from a particular stimulus (Pascualvaca et al., 1998).  Similar findings have 
been replicated in subsequent studies, with factor analysis indicating diminished 
performance on the focus/execute and shifting components, but not for sustain or encode 
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components, of Mirsky’s model of attention for individuals with high functioning autism 
(Goldstein, Johnson, & Minshew, 2001). 
 Congenital Hypothyroidism.  Individuals with congenital hypothyroidism (CH) 
also evidence difficulties with attention secondary to fluctuating thyroid hormone levels 
(Rovet & Hepworth, 2001).  Research on deficient thyroid hormone levels in animal 
models has suggested that problems with neurodevelopment may result, with a particular 
impact on cortical structures that later become important for attention such as the 
hippocampus, parietal cortex, and caudate, each of which is highly thyroid hormone 
dependent (Bernal & Nunez, 1995; Rovet & Hepworth, 2001).  Using a retrospective 
design to examine previous attention data from adolescents with CH, Rovet and 
Hepworth (2001) attempted to characterize specific attention deficits in this population 
using Mirsky’s model of attention.  Attention deficits were evident for adolescents with 
CH compared to a control group, with particular deficiencies noted on focus and inhibit 
indices based on poorer performance than controls on CPT Commissions, Trail Making 
Test Part A, WCST Accuracy and Perseverative Errors, and WISC-R Coding (Rovet & 
Hepworth, 2001).  Furthermore, specific attention deficits were correlated with certain 
disease parameters, such as more severe levels of hypothyroidism and longer duration of 
low thyroid hormone levels being associated with lower scores on the encode and focus 
indices, which provide an interesting finding that may potentially be compared to 
children with CKD (Rovet & Hepworth, 2001).  However, it is important to consider the 
implications of treatment differences between CH and CKD patients as it relates to 
attention in these populations, because thyroid hormone therapies are very effective 
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treatments for alleviating thyroid dysfunction whereas treatments for CKD that restore 
kidney function do not exist. 
 Fetal Alcohol Exposure.  Children whom experience fetal alcohol exposure (FAE) 
also run the risk of global and specific neuropsychological impairments.  Several studies 
on children with FAE have used case-control comparisons and principal components 
analysis (PCA) to replicate Mirsky’s findings on the multicomponent model of attention 
in this population (Burden, Jacobson, Sokol, & Jacobson, 2005; Coles, Platzman, Lynch, 
& Freides, 2002).  Burden and colleagues (2005) examined the relationship between FAE 
in elementary school children and empirically derived attentional constructs from 
Mirsky’s model of attention using PCA on the ten measures Mirsky utilized, in addition 
to a second PCA on the ten measures used by Mirsky and four additional measures used 
to examine working memory and executive function domains.  Their results were similar 
for both the original and extended PCAs, with factors reflecting elements of encode, shift, 
focused/sustained attention, along with a distinct element dealing with impulsivity 
(Burden et al., 2005).  Among the domains of attention identified in these PCAs, FAE 
was most strongly associated with poor working memory, comprised of digit span, 
arithmetic, and digit cancellation tasks (Burden et al., 2005).  Adolescents with FAE have 
also been shown to be less efficient in processing stimuli requiring visual attention than 
their healthy peers, despite similar performance on auditory attention tasks (Coles et al., 
2002).  Similar findings have also been reported for adolescents who were prenatally 
exposed to cigarettes and marijuana, with PCA results yielding a five-factor model very 
consistent with Mirsky’s (Fried & Watkinson, 2001).  Prenatal cigarette exposure was 
most associated with deficits in encode and impulsivity components of attention, and 
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prenatal marijuana exposure was most associated with deficits in attention stability (Fried 
& Watkinson, 2001). 
 Postnatal Lead Exposure.  Research on children with low levels of postnatal lead 
exposure has also indicated the potential for neurocognitive deficits, particularly within 
the domains of attention and executive functions (Chiodo et al., 2004).  Chiodo and 
colleagues (2004) assessed the neurodevelopmental effects of low levels of postnatal lead 
exposure in African American urban youths.  Specific aspects of attention were measured 
in this sample using Mirsky’s model of attention, and results suggested that lead exposure 
at least partially accounts for deficits in sustained attention based on lower total correct 
scores on auditory and visual CPT (Chiodo et al., 2004).  Differences were also noted 
within the executive functions domain on the WCST task and a verbal fluency task 
(Chiodo et al., 2004).  Regression analyses confirmed associations between 
neuropsychological dysfunction and low doses of lead exposure, suggesting that a lower 
bound threshold for postnatal lead exposure leading to these deficits was not evident 
(Chiodo et al., 2004).  This latter finding was interesting given the similarities between 
this population and children with CKD who have varying levels of native kidney function 
and fluctuating levels of uremic toxins in the blood. 
Overall, it appears that attention as characterized into multiple domains in 
Mirsky’s model has been deemed susceptible to the presence of several psychiatric and 
medical conditions in children, adolescents, and adults.  However, there appears to be 
considerable variability in the type of attention deficits noted in Mirsky’s model among 
these conditions.  Adults with PTSD and children with prenatal exposure to teratogens 
appear to have deficits in the encode and sustain domains, while children with autism 
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tend to struggle more on tasks associated with the shifting domain of attention, as one 
might expect given the behavioral phenotype of autism.  Conversely, adolescents with 
CH tend to have difficulty with tasks on the focus and inhibit domains, and children with 
postnatal lead exposure have difficulty on sustained attention tasks.  Yount and 
colleagues (1998) also showed that various psychosocial and biomedical variables were 
predictive of focused attention in adults with CKD, which has implications for the current 
study.  Based on this literature, there appears to be sufficient basis to compare how 
children with CKD manifest deficits within specific attention domains within Mirsky’s 
model of attention. 
Attention Functioning in Pediatric and Adult CKD 
The findings in the pediatric CKD literature are mixed with respect to the 
domains of attention (Fennell et al., 1990a, 1990b; Gipson et al., 2006; Mendley & Zelko, 
1999; Qvist et al., 2002).  In one of the first studies to examine attention in this pediatric 
population, Rasbury and colleagues (1983) administered the Continuous Performance 
Task (Rosvold et al., 1956; Gale & Lynn, 1972) to children and adolescents with CKD.  
No significant differences were found on this task between controls and ESRD patients at 
baseline or 1-month after receiving a transplant.  Fennell and colleagues (1990a, 1990b) 
have also reported no differences in measures of sustained attention within a 
heterogeneous sample of children with all treatment modalities of CKD versus matched 
controls.  The degree of attention impairment was related to an earlier age of onset and 
duration of the CKD.  More recently, Mendley and Zelko (1999) reported improvements 
in sustained attention and mental processing speed one year after transplant in their 
sample of 9 children with CKD.  Additionally, Qvist and colleagues (2002) reported no 
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group deficits of attention in their renal transplant sample when compared with the 
normative population from the NEPSY, although 24% of their sample evidenced 
generalized attention deficits (defined as scaled score < 7 or SS < 85). 
Using a multidimensional model of executive functioning (i.e., Initiating, 
Sustaining, Set-Shifting, Inhibiting), Gipson and colleagues (2006) recently reported on 
the presence of significant problems in selected executive functions in their sample of 
children with CKD when compared to a typically-developing comparison group.  The 
CKD group performed poorer than the control group in the Initiation and Sustaining 
domains, after controlling for chronological age and IQ.  The groups did not differ on 
Set-Shifting or Inhibition.  These findings suggested the possibility that the progression 
of renal disease may disrupt selected aspects of attention and executive functions beyond 
the generalized effects of lower IQ.  With this same sample of CKD patients, Slickers and 
colleagues (2007) also recently identified associations between clinical variables and 
specific neurocognitive deficits.  In this study, attention and disease severity were not 
correlated significantly (Slickers et al., 2007); however, prospective memory was 
significantly correlated with higher levels of disease severity (p < .01) and longer 
duration of disease (p < .04) in this sample (Slickers et al., 2007). 
In adults with CKD, studies have generally examined the integrity of attention in 
patients with CKD as it relates to kidney failure and, more specifically, the effects of 
dialysis treatment.  Heilman and colleagues (1975) reported significant differences 
between uremic (ESRD) patients and controls on immediate memory, which was 
postulated to manifest through poor arousal due to complications of uremia and below 
average rehearsal skills.  These difficulties with higher-order cortical functions on novel 
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problem-solving tasks have been replicated elsewhere (Ginn, 1975; Souheaver, Ryan, & 
DeWolfe, 1982), and suggested a specific pattern of deficits in attention and executive 
domains for adults with CKD (Hart, Pederson, Czerwinski, & Adams, 1983; McDaniel, 
1971).  This coincided with a previously widely held belief that uremia and ESRD 
reduced global attention functioning (Marshall, 1979; Nissenson, Levin, Klawans, & 
Nausieda, 1977; Stewart & Stewart, 1979).  However, these findings have been 
inconsistent with other results (Heilman et al., 1975; Souheaver et al., 1982) suggesting 
intact auditory attention for tasks requiring passive reception of auditory stimuli and 
minimal organization of verbal material (e.g., Digit Span tasks). 
Additionally, previous studies that measured performance on CPTs with adult 
CKD patients have been inconclusive regarding differential performance patterns in this 
population (Alexander, Hightower, Anderson, & Snow, 1980; Rasbury, Fennell, 
Eastman, Garin, & Richards, 1979; Umans & Pliskin, 1998).  Slowed reaction time has 
been implicated in at least one previous study with adults with uremia (Alexander et al., 
1980); nevertheless, other CPT variables (e.g., errors of omission and commission, total 
correct, variability) have not shown differential performance patterns for patients with 
CKD.  In this sense, the available studies on attention processes in adults with CKD are 
inconsistent and suffer methodological limitations (e.g., small sample sizes, wide age 
ranges, heterogeneous severity of kidney failure within samples, adequacy of dialysis 
delivery not assessed) that make generalization of these findings in the contemporary 
ESRD population difficult. 
Similar to findings in the pediatric CKD literature, neuropsychological 
performance, and specifically attention functioning, has also been reported to improve 
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after transplantation and hemodialysis in adults with ESRD.  Teschan and colleagues 
(1976) found significant improvements in choice reaction time and memory scores 
following transplant in adults with ESRD.  In a later study that included a heterogeneous 
group of adult CKD patients and a control group, Teschan and colleagues (1979) found 
that transplant patients performed at a comparable level to the control group on attention 
and working memory tasks, although results comparing the dialysis and transplant groups 
were not presented.  More recently, several studies have reported improved performance 
after renal transplantation in adults on tests of attention, executive function, and working 
memory (e.g., Trail Making Test, Symbol Digit Modalities Test, Rey Auditory Verbal 
Learning Test) and on EEG patterns (Griva et al., 2004; Kramer et al., 1996). 
The temporal effects of different types of dialysis (e.g., hemodialysis versus 
peritoneal dialysis) on attention in adults with ESRD have also been examined recently 
(Griva et al., 2003).  This is an important consideration to make, as peritoneal dialysis is a 
continuous treatment that patients undertake on a daily ongoing basis whereas 
hemodialysis requires approximately three dialysis sessions per week when purified 
water filtration of the patient’s blood is conducted.  The research on the potential 
temporal effects on attention differences for hemodialysis versus peritoneal patients has 
suggested significantly greater improvements on tasks of attention, concentration, and 
memory in hemodialysis patients 24-hours post-dialysis than for peritoneal dialysis 
patients who typically received daily therapy (Griva et al., 2003). 
Overall, it appears that scores of attention and executive functions are lower than 
normal to a certain degree in both pediatric and adult CKD patients.  The available 
literature is inadequate to fully characterize this effect among renal replacement 
 35 
modalities or severity of renal disease with regards to specific aspects of attention, and 
findings are somewhat inconsistent.  Further research is warranted in this particular area 
of neurocognitive functioning to examine attention functions in children with CKD. 
Attention Functioning in Other Pediatric Medical Conditions 
Recent research on medical illnesses has increasingly focused on the link with, 
and the potential functional consequences of, attention and executive impairments.  
However, the medical literature has not yet developed to the point of using meta-analysis 
techniques to systematically review the degree of attention and executive dysfunction 
across various medical illnesses (Schillerstrom, Horton, & Royall, 2005).  Studies on 
children and adults with modest sample sizes have found modest to strong associations 
between impairments in attention and executive functions and several medical illnesses 
(Schillerstrom et al., 2005), including diabetes (McAulay, Deary, Sommerfield, & Frier, 
2005; Rovet & Alvarez, 1997), spina bifida (Dennis et al., 2006), sickle cell disease (Kral 
et al., 2001; Noll et al., 2001), pediatric HIV/AIDS (Armstrong et al., 2003; Bisiacchi et 
al., 2000; Brouwers et al., 1994), and cancer (Vannatta & Gerhardt, 2003).  Examining 
the differential effects of attention and executive dysfunction in these medical 
populations may provide additional insight into the impact of attention deficits for 
children with CKD. 
Diabetes 
Children with diabetes mellitus face a variety of neurocognitive complications 
associated with suboptimal control of glucose levels.  With regards to the integrity of 
attention in this population, acute episodes of hypoglycemia have been consistently 
linked to generalized attention deficits in adults with Type 1 diabetes (McAulay et al., 
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2005) while children and adolescents with Type 1 diabetes demonstrate differential 
performance among specific domains of attention (Rovet & Alvarez, 1997).  Specifically, 
children and adolescents with Type 1 diabetes with a history of hypoglycemic seizures 
and higher blood glucose levels have demonstrated more difficulties than healthy controls 
with the selecting, focusing, and inhibiting components of attention, along with intact 
sustaining, suppressing, and shifting attentional components (Rovet & Alvarez, 1997).  
These attention deficits have been found not to resolve up to six years after initial 
diagnosis, particularly for children with onset of Type 1 diabetes prior to 4 years of age 
(Northam et al., 2001).  Single-subject design studies have also shown that children with 
Type 1 diabetes engaged in off-task classroom behavior between 23%-39% of time 
observed prior to the introduction of an insulin pump (Daley, Wodrich, & Hasan, 2006).  
In summary, cognitive impairments, such as deficits in attention and mental processing, 
for children with Type 1 diabetes tend to be linked to physiological factors associated 
with this disease, including earlier age of onset and moderate to severe episodes of 
hypoglycemia (Ferguson et al., 2005; Hannonen, Tupola, Ahonen, & Riikonen, 2003; 
Kaufman, Epport, Engilman, & Halvorson, 1999; Ryan, Vega, & Drash, 1985; Ryan et 
al., 1990). 
Spina Bifida 
Children and adolescents with spina bifida face a variety of neurocognitive 
problems associated with incomplete neural tube formation during early prenatal 
development (Dennis et al., 2006).  Deficits in attention orienting have been reported in 
infants with spina bifida on tasks of facial saliency (Landry, Lomax-Bream, & Barnes, 
2003).  School-age children with spina bifida, when compared with their healthy peers, 
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have been shown to orient more slowly and take longer to disengage from stimuli that 
have captured their attention (Dennis et al., 2005a).  Current estimates on the prevalence 
of children with spina bifida meeting criteria for ADHD has suggested that rates exceed 
that of the general population, ranging between 30-40%, with ADHD-Inattentive type 
being more predominant (Burmeister et al., 2005; Davidovitch et al., 1999).  Inhibition of 
return (i.e., a visual search technique in which additional time is required to locate a 
target stimulus in a previously attended location, as a means to increase the likelihood of 
locating new targets in new locations; Posner & Cohen, 1984) has also proven to be 
problematic in this pediatric population, as brain dysmorphologies of the midbrain (e.g., 
superior colliculus) have been linked to this covert shifting of attention (Dennis et al., 
2005b).  Deficits in arithmetic processing skills have also been documented in children 
with spina bifida, with connections made to attention through accompanying visual-
spatial and processing speed deficits (Ayr, Yeates, & Enrile, 2005; Barnes et al., 2006).  
Neurocognitive deficits, particularly in the areas of executive dysfunction and 
distractibility, also tend to be more prevalent for children with spina bifida and 
accompanying hydrocephalus (Horn, Lorch, Lorch, & Culatta, 1985; Iddon, Morgan, 
Loveday, Sahakian, & Pickard, 2004). 
Sickle Cell Disease 
 Research on the cognitive functioning of children with sickle cell disease (SCD) 
has indicated domain-specific deficits in attention for this pediatric population (Brown et 
al., 1993; Kral et al., 2001).  This is evident for children with SCD with (Brown et al., 
2000; DeBaun et al., 1998) and without (Noll et al., 2001) a history of previous overt or 
silent strokes, with the frontal lobe proposed as the primary site of injuries.  Recent 
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research has also suggested that the cortical location of ischemic lesions and infarcts have 
direct implications on attention in children with SCD (Schatz et al., 1999).  Attention 
deficits and executive dysfunction in pediatric SCD patients have been linked to anterior 
cerebral infarcts (Schatz et al., 1999).  Global intellectual deficits and academic problems 
appear to be more common for children with SCD and overt strokes (Armstrong et al., 
1996; Swift et al., 1989), and global neurocognitive delays can occur as early as within 
the first 3 years of life (Thompson, Gustafson, Bonner, & Ware, 2002).  The literature 
seems to indicate that specific domains of neurocognitive functioning should be 
examined for children with SCD, particularly for those with overt and/or silent strokes 
(Kral et al., 2001; Lemanek et al., 2003; Schatz et al., 1999). 
Pediatric HIV/AIDS 
Deficits in attention have also been reported in school-age children with HIV 
infection.  However, the research is limited with respect to older children and adolescents 
because of the small number of trials being conducted and because cohorts of children 
with HIV/AIDS are only recently beginning to survive in larger numbers to participate in 
these studies, with the help of antiretroviral therapies (Armstrong et al., 2003).  Given the 
progressive course of pediatric HIV/AIDS and the long-term implications of 
antiretroviral therapies, adolescents and young adults have been shown to exhibit 
neurocognitive deficits and symptoms consistent with AIDS-related dementia in the adult 
HIV literature (Armstrong et al., 2003; Melton, Kirkwood, & Ghaemi, 1997), with 
memory and frontal lobe functions such as impaired judgment and reasoning being the 
most impacted (Simpson & Berger, 1996).  Findings with respect to attention in school-
age children are somewhat inconsistent (Armstrong et al., 2003).  Although some 
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children may appear asymptomatic at a given age in school and global cognitive deficits 
tend to be rare, recent estimates suggest that executive functioning and attention 
problems are specifically common in both preschool and school-age children with 
HIV/AIDS (Bisiacchi et al., 2000; Brouwers et al., 1994).  In fact, other research has 
suggested that possibly half of children with HIV/AIDS experience significant enough 
school difficulties from specific functional deficits to warrant special education services 
(Mialky, Vagnoni, & Rutstein, 2001).  Researchers have speculated on the impact of HIV 
on the development of specific attention mechanisms in the developing brain (Armstrong 
et al., 2003), as neurological compromise due to cerebral atrophy, ventricular 
enlargements, cerebral calcifications, reduction of white matter, and demyelination 
contribute to CNS and static encephalopathy in pediatric HIV/AIDS (Mintz, 1999).  In 
this sense, the literature suggests that subtle neurocognitive impairments may be an 
additional consideration for pediatric HIV/AIDS patients, even if CNS problems and 
impaired neurodevelopment early in life do not exist for an individual (Armstrong et al., 
2003; Pearson et al., 2000). 
Pediatric Cancer 
The available literature suggests that neurocognitive deficits are evident for 
pediatric cancer patients with brain tumors, those that receive cranial radiation, and those 
that receive intrathecal chemotherapy to decrease CNS involvement of acute 
lymphoblastic leukemia (ALL; Butler & Copeland, 1993; Powers, Vanatta, Cool, & 
Stehbens, 1995; Vannata & Gerhardt, 2003).  Among neuropsychological domains tested 
in recent studies, deficits for pediatric cancer patients with CNS involvement have been 
apparent in the broad areas of intelligence, memory, attention, and academic functioning 
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(Lockwood, Bell, & Colegrove, 1999; Raymond-Speden, Tripp, Lawrence, & Holdaway, 
2000; Schatz, Kramer, Ablin, & Matthay, 2000).  With regards to attention, Lockwood 
and colleagues (1999) have provided evidence of global attention deficits for children 
whom have undergone cranial radiation, with differences noted for both fundamental 
attention processes (e.g., focusing, tracking, shifting), complex executive skills (e.g., 
mental switching, hypothesis formation, problems solving), and sustained attention.  In 
fact, studies have shown that irradiated childhood ALL survivors demonstrate many 
ADHD-like symptoms, including distractibility and difficulty with sustained attention 
(Brouwers & Poplack, 1990).  This propensity for attention problems has also been 
reflected in elevated rates of special education placements in this population (Haupt et al., 
1994).  Visual attention has been shown to be a specific deficit for children with ALL, 
with difficulties on attention shifting tasks being directly related to cranial radiation 
(Schatz, Kramer, Ablin, & Matthay, 2004).  Sustained attention has also been found to 
improve with methylphenidate treatments in double-blind placebo studies, with post-
treatment improvements noted on CPT measures of errors of omission (Thompson et al., 
2001).  CNS treatment and subsequent neurocognitive effects have tended to be worse for 
children who are younger at initial diagnosis (Lockwood et al., 1999; Vannatta & 
Gerhardt, 2003). 
Considerable evidence also exists indicating that neurocognitive deficits in 
pediatric cancer patients expand to include broader difficulties with adjustment and social 
functioning, including problems with social withdrawal, diminished friendships, and less 
involvement in social activities (Carpentieri, Mulhern, Douglas, Hanna, & Fairclough, 
1993; Radcliffe, Bennett, Kazak, Foley, & Phillips, 1996; Vannatta, Gartstein, Short, & 
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Noll, 1998).  Findings in these studies reflecting poorer psychosocial function for 
children with CNS malignancies are mirrored by findings in the pediatric traumatic brain 
injury (TBI) literature indicating poorer psychosocial outcomes for children who have 
sustained a TBI versus only orthopedic injuries (Andrews, Rose, & Johnson, 1998; 
Bloom et al., 2001).  For children with ALL, emerging evidence suggests that younger 
patients who undergo higher intensities of neurotoxic treatment are at considerable risk 
for both neurocognitive and social dysfunction (Chen et al., 1998; Hill et al., 1998; 
Vannatta, Zeller, Noll, & Koontz, 1998). 
Because of the dearth of studies available on this topic, it is unclear whether 
children with brain tumors consistently experience emotional and behavioral dysfunction 
that could indirectly impact attention capacities (Vannatta & Gerhardt, 2003).  The 
research has been inconsistent with this particular population, taking into account 
conflicting findings suggesting significant problems with emotional regulation upon 
parent report in addition to low scores on measures of depression upon self-report 
(Radcliffe et al., 1996).  In this sense, similar to findings regarding social functioning in 
pediatric patients with CKD, it remains to be seen whether findings suggesting emotional 
distress among brain tumor survivors reflect methodological issues related to comparing 
clinical samples to normative samples, parent report of distress that children do not 
actually experience, or an adaptive style in which brain tumor survivors repress 
emotional distress and do not inherently acknowledge its presence (Vannatta & Gerhardt, 
2003). 
In summary, based on the available literature, it appears that attention and 
executive functions are quite vulnerable in the presence of a variety of chronic medical 
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conditions in childhood.  These neurocognitive deficits have been linked to earlier age of 
disease onset, more severe forms of disease, accompanying comorbid conditions, cortical 
defects, treatments affecting CNS functioning, higher rates of special education 
placement, and decreased levels of adjustment or social functioning.  Based on this 
literature, there is a need to examine this question in children with CKD. 
Associations Among Clinical Variables and Neurocognition 
The relationship between medical variables associated with certain medical 
conditions have received increased acknowledgement recently in the literature as to the 
detrimental effects on neurocognition.  Three medical outcomes often associated with 
CKD patients are disease severity (eGFR), anemia, and hypertension.  A brief review of 
the literature on these topics is covered below, in an attempt to conceptualize how 
attention may differ among children with CKD with these considerations. 
 Slickers and colleagues (2007) have provided a contemporary examination of 
clinical predictors for neurocognitive dysfunction in children with CKD.  In their study, 
attention was operationally defined as the total number correct variable from the Gordon 
Diagnostic System, a visual CPT.  Results indicated that lower IQ and memory scores 
were correlated with increased disease severity.  Lower memory scores were also 
correlated with longer duration of disease, while lower IQ scores were correlated with 
greater percentage of life with CKD (Slickers et al., 2007).  Although attention was not 
linearly associated with disease severity in this sample, Slickers and colleagues (2007) 
reported that dichotomous comparisons between patients with mild/moderate CKD to 
those with severe CKD/ESRD yielded significant differences on IQ, memory, and 
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attention.  Anemia and hypertension did not correlate significantly with IQ, memory, or 
attention in this sample (Slickers et al., 2007). 
 The issue of disease severity has also been tackled in several other studies 
examining neurocognitive dysfunction in CKD, but most studies to date have focused 
primarily on children with ESRD.  Although it seems logical that CKD severity would be 
proportional to the degree of cognitive impairment, the data are not yet available to 
completely support this finding in the CKD population.  Results from the study by 
Slickers and colleagues (2007) argue against a threshold effect of CKD severity on 
neuropsychological outcomes; in this sense, children at all stages of CKD severity are 
potentially at risk for neuropsychological deficits.  These findings have also been 
replicated with respect to children with CKD on dialysis compared with children who 
have previously undergone a kidney transplant (Brouhard et al., 2000; Lawry et al., 
1994).  This association between disease severity and poorer neuropsychological 
outcomes is also supported by previous research in other medical populations, including 
Type 1 diabetes (Northam et al., 2001; Rovet & Alvarez, 1997), spina bifida (Horn et al., 
1985; Iddon et al., 2004), sickle cell disease (Kral et al., 2001; Schatz et al., 1999), 
pediatric HIV/AIDS (Armstrong et al., 2003), and pediatric cancer (Lockwood et al., 
1999; Vannatta & Gerhardt, 2003). 
The link between poor health outcomes and low hemoglobin/hematocrit levels is 
also clear in the literature, due to findings related to CKD, congestive heart failure, 
chronic inflammatory bowel disease, and rheumatoid arthritis (Eknoyan, 2001; 
Silverberg, Iaina, Wexler, & Blum, 2001).  The association between decreased cognitive 
function and anemia has been most widely examined in the CKD patient population 
 44 
(Marsh et al., 1991; Nissenson, 1992; Stivelman, 2000).  Stivelman (2000) has recently 
reviewed this topic to highlight several studies investigating the use of erythropoietin 
(EPO) in adult CKD patients with anemia.  Among them is a study by Marsh and 
colleagues (1991) that demonstrates an association between raising hematocrit levels and 
improvements on electrophysiological and neuropsychological measures.  Significant 
improvements were noted between pre- and post-EPO treatment on P300 event-related 
potential (ERP) amplitudes and on the executive function tasks of Symbol-Digit 
Modalities Test and Trail Making Test, Part B (Marsh et al., 1991).  Similar 
improvements on P300 ERP latencies, EEG findings, and neuropsychological tests have 
been reported elsewhere (Brown et al., 1991; Grimm et al., 1990; Nissenson, 1992; 
Sagales et al., 1993).  Pickett and colleagues (1999) have further advanced this position 
with their work on the relationship between neurocognitive functioning and altogether 
eliminating anemia in their patients.  In this study, patients on hemodialysis (n = 20) had 
their hematocrit levels normalized with EPO and experienced accompanying decreases in 
EEG slowing at higher hematocrit levels (Pickett et al., 1999).  Taken together, these 
findings seem to suggest a direct positive relationship between hematocrit/hemoglobin 
levels and higher-order cognitive functions such as attention span in CKD patients 
(Stivelman, 2000), and provides a basis for determining whether differential performance 
among neuropsychological measures of attention exist in a pediatric sample of CKD 
patients. 
The association between blood pressure and cognitive decline in adults, 
particularly for the elderly, has been firmly established in the literature (Starr, 1999; Suhr, 
Stewart, & France, 2004).  However, this association has not been examined as 
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extensively for pediatric patients with elevated blood pressure, particularly given the 
recent trend of increasing prevalence of obesity among today’s youths (Muntner, He, 
Cutler, Wildman, & Whelton, 2004).  Hypertension in the general pediatric population 
has been correlated with decreased performance in tasks requiring memory, attention and 
concentration (Lande et al., 2003).  In this population-based study by Lande and 
colleagues (2003), school-age children from a U.S. survey were diagnosed with 
hypertension on the basis of an averaged right arm systolic or diastolic blood pressure 
above the 90th percentile for age, height and gender.  Hypertension was independently 
associated with significantly lower neurocognitive scores representative of short term 
memory, attention, and concentration problems, as measured by various digit span test 
scores (Lande et al., 2003).  This work by Lande and colleagues (2003) represents the 
only population-based study on hypertension in children and adolescents. 
Retrospective studies of pediatric patients with CKD have similarly demonstrated 
an association between hypertension and neurological complications, including 
alterations in consciousness, seizures, or convulsions; additionally, children with a 
history of hypertensive encephalopathy have shown similar lowered performance patterns 
on neurocognitive assessments as those with CKD alone (Trompeter, Smith, Hoare, 
Neville, & Chantler, 1982; Uysal, Renda, Saatci, Yalaz, 1990).  In adults and children 
with ESRD, cognitive impairments have been linked to cortical defects associated with 
multiple infarcts (Lass, Buscombe, Harber, Davenport, & Hilson, 1999; Qvist et al., 
2002).  Animal models have also shown improved learning capacity on task acquisition 
for those with hypertension alone compared to those with hypertension associated with 
renal dysfunction (Widy-Tyszkiewicz, Scheel-Kruger, & Christensen, 1993).  Given the 
 46 
fact that hypertension is viewed by nephrologists as an important concern for pediatric 
patients with CKD (Swinford & Portman, 2004), it will be important to determine 
whether differences exist among the various aspects of attention as measured by Mirsky’s 
neuropsychological model of attention when comparing these patients to their healthy 
peers.
 CHAPTER III 
METHODS 
Participants 
The current study examined the integrity of specific attention domains in 30 
children with CKD, based on KDOQI Stages 2 through 5 (Table 1), compared with the 
performance of 41 typically-developing children.  CKD was operationally defined as 
kidney disease of at least 3 months duration with an estimated glomerular filtration rate 
(eGFR) < 75 mL/min/1.73m2 or dialysis-dependency.  All participants underwent 
comprehensive neuropsychological testing as part of a larger study examining 
neurocognitive outcomes in CKD, for which all participants were recruited to participate 
in accordance with the University of North Carolina Institutional Review Board 
procedures.  Findings related to demographic and related variables for both samples can 
be viewed in Table 2. 
CKD Group.  Participants were enrolled in the CKD group through face-to-face 
recruitment with a research associate at the time of their pediatric nephrology clinic 
appointments.  Enrollment occurred at the University of North Carolina Hospitals 
between 2002 and 2006.  Inclusion criteria for this group comprised those participants 
with CKD (defined as eGFR < 75 mL/min/1.73m2) or dialysis-dependency for at least 3 
months duration and chronological age between 6-18 years.  Children were excluded 
from the CKD group if there was a history of kidney transplantation in the past or the 
presence of a comorbid condition associated with severe central nervous system 
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anomalies, such as a closed-head injury, Down syndrome, or Joubert syndrome.  
Participants engaged in 2-3 neuropsychological evaluations over one year, with testing 
occurring at baseline, optionally at 6-months, and 12-months after baseline.  Results 
presented in the current study comprise baseline data only.  Participants were provided 
with monetary compensation ($50) at the completion of each study visit. 
Table 2. 
Characteristics for the CKD (n = 30) and control (n = 41) groups. 
 CKD Controls 
Chronological Age (years) 12.70 (3.32) 
(range: 6.45 – 19.04) 
11.73 (3.36) 
(range: 6.11 – 18.94) 
WASI Full Scale IQ*** 90.70 (15.59) 
(range: 64 – 127) 
113.51 (11.94) 
(range: 72 – 138) 
% Caucasian* 50.0 73.2 
% Female 46.7 43.9 
SES*** 2.93 (1.12) 4.15 (0.91) 
Age of CKD onset (years) 5.11 (6.18) 
(range: birth – 16) 
--- 
Duration of CKD (years) 6.40 (4.73) 
(range: 0 – 17) 
--- 
% Hypertensive 50.0 --- 
% Anemic 30.0 --- 
Recent School Absences** 1.97 (2.74) 
(range: 0 – 9) 
0.49 (1.39) 
(range: 0 – 5) 
Notes. *p < .05; **p < .01; ***p < .001; Continuous variables presented as: Mean (Standard Deviation). 
 As shown in Table 2, participants in the CKD group (n = 30) consisted of 
individuals receiving maintenance dialysis therapy (n = 15) and those managed with 
conservative therapies (n = 15). The etiologies of CKD included obstructive 
uropathies/dysplasias (60%), glomerular disease (33%), and genetic disorders (7%). 
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 Control Group.  Children in the control group (n = 41) were recruited by posted 
fliers, newspaper advertisements, and electronic (e.g., e-mail, website) postings within 
the catchment area of the UNC Hospitals Pediatric Nephrology subspecialty clinic.  
Control participants were selected for study participation if there was no history of 
chronic health conditions, head trauma, seizures, frank neurological or psychiatric illness, 
developmental disorder, or current medication usage other than a multivitamin.  Control 
group participants were demographically matched to the CKD patient sample on the 
variables of age, gender, race, and maternal education (collected by parent questionnaire).  
Demographic variables were collected for the control group, but medical variables were 
not collected so as to increase participation rates among volunteers.  Control group 
participants were also provided with monetary compensation ($50) at the completion of 
each study visit in a similar fashion as the CKD group. 
Procedures 
All participants and their parent/guardian provided assent and consent prior to 
testing.  Members of the CKD and control groups were tested as part of a larger study 
examining the neurocognitive effects of CKD and concurrent treatment modalities.  
Graduate students in the UNC School Psychology program were thoroughly trained in the 
use of instruments and study procedures before collecting data.  Neuropsychological 
evaluations took place in either the General Clinical Research Center of UNC Hospital or 
at the Clinical Center for Development and Learning at UNC.  Participants in the CKD 
group were tested as part of a clinical visit.  Standard procedures were in place so that 
participants in the CKD group were tested prior to undergoing medical procedures (e.g., 
blood draws) or physical examinations to control for any potential negative reactions that 
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could invalidate test results.  Participants in the control group only underwent 
neuropsychological testing and were not subject to any medical procedures. 
The neuropsychological evaluations included an extensive child assessment 
measuring various neurocognitive domains, including attention.  All neuropsychological 
instruments were administered in a standardized method in accordance with test manual 
guidelines.  Parents were also asked to fill out several informal questionnaires requesting 
information on demographic and academic data, including race and socioeconomic status 
(given the associations with IQ; see Brooks-Gunn, Keblanov, & Duncan, 1996), previous 
grade retention, and recent school absences.  Clinical variables, including disease severity 
(eGFR), duration of disease, age of onset, and comorbid diagnoses (e.g., anemia, 
hypertension) were obtained for participants in the CKD group from a physical 
examination with the patient’s pediatric nephrologist.  SES was defined by maternal 
education, which was nominally coded (1 = some high school, 2 = high school graduate 
or GED recipient, 3 = progress towards bachelor’s degree or completed associate’s 
degree, 4 = completed bachelor’s degree, 5 = completed graduate or professional degree).  
Recent school absences were defined as number of absences in the last 30 days, or in the 
last month of the school if the visit occurred when classes were not in session. 
Instruments 
All participants received a variety of attention-related tasks.  Measures were 
selected to align with the five-factor attention model posited by Mirsky and colleagues 
(Mirsky, 1987, 1989, 1996; Mirsky et al., 1991, 1995a, 1995b, 1999).  These included 
selected variables from the Tower of London Test (TOL; Total Move, Total Execution 
Time scores), Gordon Diagnostic System (GDS; Total Correct, Mean Response Time, 
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Correct Variability scores), Keith Auditory Continuous Performance Test (ACPT; Total 
Correct, Correct Variability scores), Ruff Figural Fluency Test (RFFT; Perseverations 
Total score), and the Wide Range Assessment of Memory and Learning (WRAML; 
Finger Windows and Number/Letter subtest scores).  Age-based standard scores (mean = 
100, standard deviation = 15) were generated from available normative data when 
possible.  When normative data were not available for particular age ranges (e.g., RFFT 
Perseverations, Keith ACPT Correct Variability scores), group means and standard 
deviations were generated from control group data.  Higher standard scores reflect better 
performance in all analyses.  As such, standard scores were reversed during conversions 
in instances when higher raw scores indicate poorer performance (e.g., TOL Total Move, 
Execution Time; GDS Mean Response Time; GDS/ACPT Correct Variability; RFFT 
Perseverations) to ease comparisons.  The Wechsler Abbreviated Scale of Intelligence 
was also used as an estimate of overall intellectual functioning.  All tasks were 
administered by trained examiners who were supervised by a child neuropsychologist. 
Tower of London, Second (Drexel University) Edition (TOL).  This problem 
solving task involves placing three beads on three pegs in a variety of configurations to 
match the pattern presented by the examiner.  Several standard scores can be derived 
from the participant’s performance including Total Test score, Initiation Time, Problem-
Solving Time, Execution Time, Rule Violations, and Time Violations.  Normative data 
are available for ages 6 years and above (Culbertson & Zillmer, 2001).  Variables used 
for the current study included Total Test and Execution Time scores, both of which were 
reversed when converting from raw scores to standard scores to ease comparisons of the 
data. 
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Gordon Diagnostic System (GDS).  The Vigilance portion of this task requires the 
participant to respond to specific visual stimuli (e.g., press the button when the number 1 
followed by the number 9 is presented) from a series of numbers presented at a rate of 
about one per second.  The GDS consists of three blocks of 15 possible correct responses 
over the span of 9 minutes.  The task yields standard scores for the Total Correct, Correct 
Variability, Commissions, Commission Variability, Mean Response Time, and Response 
Time Variability.  Normative data are available for ages 6 years and above (Gordon, 
1986).  Variables used in the current study included Total Correct, Mean Response Time, 
and Correct Variability scores, the latter two of which were reversed during standard 
score conversions. 
Keith Auditory Continuous Performance Test (ACPT).  This task of auditory 
attention requires the participant to raise his/her hand every time the word “dog” is read 
from a list of words.  The list contains 96 total words and goes through 6 iterative blocks, 
each with a total of 20 presentations of “dog.”  This task yields standard scores for Total 
Correct and Total Error (omissions and commissions) scores.  Normative data are 
available for children 6 years and above (Keith, 1994; Sykes, Douglas, & Morgenstern, 
1973).  Variables used in the current study included the Total Correct score and a Correct 
Variability score, which was calculated from the mean variance of correct responses by 
block for the control group. 
Ruff Figural Fluency Test (RFFT).  This task requires the participant to generate 
as many unique designs as possible by connecting two or more dots across a series of dot 
formations in a 60 second time period.  There are five different trials, with distractors 
being present in two of the presentations.  Standard scores include the number of unique 
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designs and the number of perseverations.  Normative data are available for children and 
adolescents (Evans, Ruff, & Gualtieri, 1985; Vik & Ruff, 1988) as well as for individuals 
16 years of age and older (Ruff, 1996).  The Perseverations score was used in the current 
study.  This variable was calculated for the entire sample using the mean number of 
perseverative responses for the control group, due to the fact that available normative 
data did not encompass the entire age range of this sample. 
Wide Range Assessment of Memory and Learning (WRAML).  The WRAML 
includes 9 different subtests that measure short-term verbal memory (Story Memory, 
Sentence Memory, Number/Letter), short-term visual memory (Picture Memory, Design 
Memory, Finger Windows), and new learning capabilities (Sound Symbol, Visual 
Learning, Verbal Learning).  Subtest scores are provided as scaled scores (mean = 10, 
standard deviation = 3), and a General Memory Index can also be computed from the 9 
subtests.  Normative data are available for ages 6 through 17 years, 11 months (Adams & 
Sheslow, 1990). 
The WRAML was administered and scored according to standardized procedures.  
However, three participants, one in the CKD group and two in the control group, were 
administered WRAML subtests despite being out of age range for this test (i.e., 18-19 
years of age).  Normative data for 17 year-olds were used for score conversions with 
these three participants given their close proximity in age to the normative sample.  
Additionally, all three participants were still in high school and therefore closely 
resembled the experiential profile of participants in the normative sample. 
The Number/Letter and Finger Windows subtests were used for data analyses in 
the present study.  The Number/Letter subtest is a task in which the participant is asked to 
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repeat a random mix of both numbers and letters verbally presented.  The Finger 
Windows subtest measures the participant’s attentiveness to a rote visual pattern by 
manually reproducing a demonstrated spatial sequence as the examiner points to 
increasingly longer series of locations found on a card.  These two subtests are verbal and 
visual analogs of one another, in that both deal with immediate recall of discrete and non-
meaningful information.  Scaled scores from the Finger Windows and Number/Letter 
subtests were converted to standard scores for ease of comparison. 
Wechsler Abbreviated Scale of Intelligence (WASI).  The WASI is built on the 
well-known Wechsler measures of global intellectual functioning.  It was designed for 
ages 6 years through adulthood, and employs a fluid-crystallized model of intelligence 
(Wechsler, 1999).  Four subtests comprise the WASI including Vocabulary, Block 
Design, Similarities, and Matrix Reasoning.  All four subtests were administered to gain a 
brief IQ score. 
Attention domains by Measurement Outcomes 
Outcome measures from each of the above instruments were used to match onto 
attention domains in Mirsky’s model.  The exact measures used in Mirsky’s factor 
analytic studies were used when available to the researcher and when that particular 
measure was appropriate to use with pediatric patients.  When this was not the case, 
measures analogous to those used in Mirsky’s model were employed.  Each domain 
utilized two outcome measures to assess attention across the five domains of Mirsky’s 
model.  A breakdown of the distribution of outcome measures among the five domains in 
Mirsky’s model of attention can be seen in Table 3. 
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Table 3. 
Measurement variables organized by attention domain. 
Attention Domains Measures Used 
Focus / Execute - GDS Mean Response Time 
- TOL Execution Time 
Sustain - GDS Total Correct  
- ACPT Total Correct 
Stability - GDS Correct Variability 
- ACPT Correct Variability 
Shift - TOL Total Score 
- Ruff Perseverations Score 
Encode - WRAML Number/Letter subtest 
- WRAML Finger Windows subtest 
 
Focus/Execute.  To assess how participants concentrate attentional resources on 
tasks under timed conditions, screen out distractors, and respond rapidly to the demands 
of tasks, two variables from the previously described tasks were employed.  Mean 
Response Time from the GDS and Execution Time from the TOL were the variables used 
to measure the Focus/Execute domain of Mirsky’s model.  These variables were selected 
due to the high degree of association between the task demands for both measures and 
those measured within this domain of Mirsky’s model, in addition to a moderate internal 
consistency (α = 0.56) with one another.  Both tasks require participants to maintain their 
concentration, ignore distractions, and respond rapidly, which are the main aspects of the 
Focus/Execute domain in Mirsky’s model. 
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Sustain.  The GDS and ACPT Total Correct variables were used to measure 
participants’ abilities to maintain attention to task over an extended period of time, which 
is the hallmark of the Sustain domain in Mirsky’s model of attention.  These variables 
were selected due to their similarity with variables historically used in Mirsky’s model 
(i.e., total number of correct responses from the CPT) as well as a strong internal 
consistency (α = 0.65) with one another. 
Stability.  In order to measure the degree of consistency of attentive responses 
over time, variables from the GDS and ACPT were also used to determine participants’ 
stability of attention.  The degree of variability among the three trial blocks on the GDS 
yield scores for Correct Variability, which determines the consistency of participants’ 
visual sustained attention over the course of the task.  Correct Variability on the ACPT 
among Iterations 1, 2, 3, 4, 5, and 6 provided an outcome analogous to GDS Correct 
Variability to measure the stability of auditory attention over time.  These outcome 
measures were paired together because they are in line with those utilized in Mirsky’s 
model and have a moderate internal consistency (α = 0.53) with one another. 
Shift.  The ability to efficiently shift attention from one salient aspect of a task to 
another was measured across visual-spatial and visual-constructive domains.  The current 
study first employed the TOL Total score to measure an individual’s ability to shift 
attentive problem-solving strategies among 10 arrangements of beads on pegs.  The 
RFFT Perseveration variable was also used to provide a measure of visual-constructive 
set-shifting as individuals attempt to avoid repeating similar designs within each of five 
trials.  These measures are analogous to the set-shifting component of the WCST used in 
Mirsky’s original model, and have been used previously in studies in which set-shifting 
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was measured (Gipson et al., 2006; Hooper et al., 2002).  They also exhibited a moderate 
internal consistency (α = 0.49) with one another in the current study. 
Encode.  The measurements of working memory capacity utilized for the current 
study included the Number/Letter and Finger Windows subtests from the WRAML.  
These two measures were selected in order to cover verbal and visual working memory 
abilities, respectively.  These measures align with the suggestion of digit span tasks made 
in Mirsky’s model of attention, and had a moderate internal consistency (α = 0.67). 
Preliminary Data Analyses 
Prior to conducting statistical analyses, the domains within Mirsky’s model of 
attention were calculated.  Age-based standard scores (mean = 100, standard deviation = 
15) were calculated from normative data for the following variables: TOL Total Move, 
Total Execution Time; GDS Total Correct, Mean Response Time, Correct Variability; 
ACPT Total Correct.  Scaled scores (mean = 10, standard deviation = 3) from WRAML 
subtests (Finger Windows, Number/Letter) were converted to standard scores for ease of 
comparison.  When normative data were not available (e.g., RFFT Perseverations, Keith 
ACPT Correct Variability scores), group means and standard deviations were generated 
from control group data to calculate standard scores for the entire sample.  Standard 
scores were reversed during the conversion process when higher raw scores reflected 
poorer performance on certain variables (i.e., TOL Total Move, Execution Time; GDS 
Mean Response Time; GDS/ACPT Correct Variability; RFFT Perseverations), so that 
higher standard scores indicated better performance in all statistical comparisons.  Once 
standard scores were generated for all variables, alpha coefficients were calculated as 
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reliability measurements to assess the internal consistency within each attention domain 
to determine if the selected measures were appropriate for use. 
Preliminary analyses compared the CKD and control groups on the variables of 
gender, race, SES, and IQ scores to determine whether the groups differed systematically 
on any of these variables.  If differences between the groups were evident on any of these 
variables with the potential to confound results, each was examined for its contribution to 
attention and then a decision was made whether to use it as a covariate in subsequent 
analyses.  If no differences between groups were found, subsequent analyses were 
conducted without using any of these variables as covariates.  However, chronological 
age was chosen a priori as a covariate for all subsequent analyses given the wide age 
range in the entire sample. 
Research Questions, Hypotheses, and Data Analyses 
Question 1 
Do specific domains of attention in children and adolescents with CKD differ 
significantly from those measured in typically-developing children and adolescents? 
Hypothesis 1 
It was hypothesized that children with CKD would be at increased risk for 
attention problems when compared to a matched control group.  Specifically, it was 
expected that the performance of children with CKD would be lower than the control 
group in the following attention domains: Focus/Execute, Sustain, and Encode.  It was 
also hypothesized that the CKD group would exhibit similar performance to the control 
group on the Stability and Shift attention domains.  Available research suggests negative 
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outcomes in specific domains of attention for children and adolescents with CKD 
(Fennell et al., 1990a, 1990b; Gipson et al., 2006; Qvist et al., 2002; Yount et al., 1998). 
Data Analysis 1 
Scores on the five attention domains posited by Mirsky were compared between 
the CKD and control groups using MANCOVA (chronological age as the covariate) and 
univariate procedures.  Estimates of effect sizes were calculated using Cohen’s d (Cohen, 
1988), using standard definitions for small (d = 0.2-0.4), medium, (d = 0.5-0.7), and large 
(d > 0.8) effect sizes.  SPSS was used to conduct all statistical analyses. 
Question 2 
Do pediatric patients with CKD differ significantly from typically-developing 
children in their observed proportion of attention problems?  Specifically, does a 
higher proportion of pediatric patients with CKD evidence difficulties with attention one 
standard deviation or more below the mean (i.e., SS < 85)? 
Hypothesis 2 
Existing research on neurocognitive outcomes in children with CKD has found 
evidence of increased prevalence of neurocognitive deficits in the CKD population 
(Duquette et al., 2007; Qvist et al., 2002).  It was hypothesized that a higher proportion of 
children in the CKD group would demonstrate attention problems (SS < 85) relative to 
the control group within several specific attention domains (Focus/Execute, Sustain, and 
Encode).  It was also hypothesized that children in the CKD group would demonstrate 
similar proportions of problems on the Stability and Shift attention domains. 
Data Analysis 2 
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The proportion of cases with attention dysfunction in the CKD and control groups 
was compared for each of the five attention domains using Pearson’s Chi-square analyses 
in crosstabs in SPSS.  An alpha level of .01 was used for these comparisons by utilizing a 
Bonferroni correction for the 5 analyses (i.e., .05/5). 
Question 3 
What functional- (e.g., recent school absences, IQ), family- (e.g., SES), and 
disease-related (e.g., disease severity, age of onset, duration of disease) variables 
predict attention domain scores? 
Hypothesis 3 
It was hypothesized that lower IQ scores, higher numbers of school absences, 
lower SES, earlier age of CKD onset, longer duration of CKD, more severe levels of 
CKD (i.e., lower eGFR calculations; NKF, 2002; see Table 1), and co-morbid diagnoses 
of anemia or hypertension would be associated with lower scores on all attention domains 
(Focus/Execute, Sustain, Stability, Shift, Encode).  Furthermore, it was hypothesized that 
IQ scores, SES, and CKD severity (eGFR) would be significant predictors of all five 
attention domains within the proposed model of attention. 
Data Analysis 3 
 A correlation matrix was constructed on CKD group data to examine the 
relationships among all measures, including intercorrelations among attention domain 
scores, IQ, recent school absences, SES, eGFR, age of CKD onset, duration of CKD, and 
anemia/hypertension status.  Up to three variables with the highest degree of correlation 
with attention domains were included as predictor variables in separate regression 
equations for each of the five attention domains.  A ratio of 10 cases for each variable 
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included in the regression equation was utilized to ensure statistical power and 
confidence in the regression analyses and subsequent regression weights.
 CHAPTER IV 
RESULTS 
Preliminary Analyses 
Reliability estimates were calculated among the ten variables selected for use in 
this study, and Cronbach’s alpha coefficients suggested that the variables exhibited 
internal consistency within each attention domain (Focus/Execute, α = 0.56; Sustain, α = 
0.65; Stability, α = 0.53; Shift, α = 0.49; Encode, α = 0.67).  Internal consistency for the 
all attention variables was also appropriate (α = 0.79).  Given these findings, the attention 
domains were calculated as described above by calculating the arithmetic mean of the 
two variables assigned to each attention domain. 
Several t-tests were conducted to evaluate group differences between the CKD 
and control groups with respect to chronological age and IQ.  For each ANOVA, the 
independent variable (i.e., disease status) included only two levels: CKD versus the 
control group.  Pearson’s Chi-square tests were run to compare the groups on the 
variables of SES, gender, and race. 
Chronological age.  Results from an independent samples t-test revealed no group 
differences on the mean age of participants at testing, t(69) = 1.21, p = .23.  However, as 
mentioned previously, chronological age was used as a covariate in subsequent analyses 
given the wide age range of the entire sample. 
Full Scale IQ.  The CKD and control groups differed significantly in their overall 
levels of intelligence based on the Full Scale IQ score from the WASI, t(69) = 6.99, p < 
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.001.  The mean score for the CKD group fell at the lower end of the average range 
(Table 2), indicating a slight downward shift in scores for the group as a whole.  Because 
general intellect can be an important factor in the integrity of attention, IQ scores from 
the WASI were covaried in later analyses. 
Socioeconomic status.  A chi-square test revealed significant differences between 
the two groups on SES, χ2 = 20.06, p < .001.  In general, the mean SES levels for both 
groups indicated that most of the mothers had achieved a high school degree and perhaps 
some post high school education/training.  Because the Full Scale IQ score from the 
WASI and maternal education scores were moderately correlated (r = 0.597, p < .001), 
SES was not used as a covariate in subsequent analyses. 
Gender and Race.  A chi-square test indicated that the CKD and control groups 
were not significantly different in terms of gender distribution (χ2 = 0.53, p = .82).  
Gender was therefore not used as a covariate in subsequent analyses.  The groups differed 
only slightly in relation to race (χ2 = 4.01, p = .045).  Given the lack of effect of race on 
attention functions found previously in the literature (see Samuels et al., 1998, 1999), 
race was not used as a covariate in subsequent analyses. 
Question 1 
Do specific domains of attention in children and adolescents with CKD differ 
significantly from those measured in typically-developing children and adolescents?  
It was hypothesized that children with CKD would be at increased risk for attention 
problems when compared to a matched control group.  Specifically, it was expected that 
the performance of children with CKD would be lower than the control group in the 
following attention domains: Focus/Execute, Sustain, and Encode.  It was also 
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hypothesized that the CKD group would exhibit similar performance to the control group 
on the Stability and Shift attention domains. 
Descriptive statistics, including means and standard deviations adjusted for age 
and IQ scores, for the CKD and control groups are presented in Table 4.  Scores for the 
control group were arithmetically higher than those for the CKD group across attention 
domains.  Visual inspection of the data indicated that mean scores for both groups on all 
attention domains were within one standard deviation of the overall mean. 
Table 4. 
Attention by group (CKD, n = 30; control, n = 41) and domain adjusted for age and IQ. 
 CKD  Control 
 M SD  M SD F-Tests Effect Size 
Focus/Execute* 94.67 11.43  99.73 8.51 4.58 0.50 
Sustain* 94.37 16.24  103.30 14.83 5.80 0.57 
Stability* 87.22 18.29  96.97 16.31 5.59 0.56 
Shift 91.50 11.02  95.74 11.88 2.10 0.35 
Encode*** 88.67 9.38  99.47 10.13 19.61 1.07 
Notes. *p < .05; **p < .01; ***p < .001; Effect size presented as Cohen’s d. 
A multivariate analysis of variance (MANOVA) was performed to determine 
whether the CKD and control groups differed from one another on the five attention 
domains (Focus/Execute, Sustain, Stability, Shift, Encode).  Chronological age and the 
Full Scale IQ score from the WASI were entered as covariates to control for between-
group differences and possible confounding factors.  Age was entered as a covariate 
variable to control for the effect of task demands by age across the wide age range in the 
entire sample.  Using IQ scores as a covariate variable also helped to ensure that 
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differences could be attributed to group membership and not to overall intelligence.  The 
domain means by group can be found in Table 4. 
All assumptions necessary for MANCOVA were evaluated prior to running these 
analyses.  To test for the assumption that the covariance matrices of the groups were 
equal, Box’s M was examined and produced a non-significant result (p = .59).  This 
suggested that the covariance matrices were not equivalent and could be pooled into one 
matrix.  The data set was also inspected and analyzed to determine whether it met the 
assumptions of MANOVA set forth by Tabachnick and Fidell (2001).  For the current 
study samples, the data were found to be univariately normally distributed and therefore 
no problems with multivariate normal distributions were anticipated.  All assumptions 
related to linearity, homogeneity of regression, and the absence of multicollinearity and 
singularity were also met.  The reliability of the covariates, chronological age and the 
Full Scale IQ from the WASI, were also found to be adequate.  The adequacy of the Full 
Scale IQ score was confirmed by the psychometric properties of the WASI, including 
good reliability and validity.  Additionally, two outliers were identified in the data set and 
were recoded to be within 3 standard deviations from the group mean using a Windsor 
procedure.  This helped to ensure that error rates were not overinflated while still keeping 
these two data points in the analysis. 
Pillai’s trace (PT) for the MANCOVA revealed a non-significant interaction 
between the WASI Full Scale IQ and the groups, F(5, 63) = 1.53, p = .20, and between 
chronological age and the groups, F(5, 63) = 0.72, p = .61.  This finding suggested that 
the MANCOVA could be interpreted for the attention domains.  Results from the 
MANCOVA indicated that the CKD and control groups differed across attention domains 
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as evidenced by a significant Wilks’ Lambda, F(5, 63) = 3.32, p = .01, d = 0.83.  Follow-
up univariate procedures indicated that the control group differed from the CKD group on 
the Focus/Execute, F(1, 67) = 4.58, p = .04, d = 0.50; Sustain, F(1, 67) = 5.80, p = .02, d 
= 0.57; Stability, F(1, 67) = 5.59, p = .02, d = 0.56; and the Encode domains, F(1, 67) = 
19.61, p < .001, d = 1.07.  The CKD and control groups did not differ significantly with 
respect to group comparisons on the Shift (p = .15, d = 0.35) domain. 
Question 2 
Do pediatric patients with CKD differ significantly from typically-developing 
children in their observed proportion of attention problems?  Specifically, does a 
higher proportion of pediatric patients with CKD evidence difficulties with attention one 
standard deviation or more below the mean (i.e., SS < 85)?  It was hypothesized that a 
higher proportion of children in the CKD group would demonstrate attention problems 
(SS < 85) relative to the control group within several specific attention domains 
(Focus/Execute, Sustain, and Encode).  It was also hypothesized that children in the CKD 
group would demonstrate similar proportions of problems on the Stability and Shift 
attention domains. 
The two groups were compared on each of the five attention domains using chi-
square tests to determine whether the proportion of cases whose attention domain scores 
fell one standard deviation or more below the mean differed between groups, as shown in 
Table 5.  The CKD and control groups differed in the frequency with which they 
experienced significant attention dysfunction on selected domains.  The proportion of 
scores more than one standard deviation below the mean differed significantly between 
groups on the domains of Shift, χ2 (1, n = 71) = 7.84, p = .005; and Encode, χ2 (1, n = 71) 
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= 10.73, p = .001.  The proportion of participants with attention dysfunction was similar 
between groups on the domains of Focus/Execute, χ2 (1, n = 71) = 1.52, p = .22; Sustain, 
χ
2
 (1, n = 71) = 2.46, p = .12; and Stability, χ2 (1, n = 71) = 1.75, p = .19. 
Table 5. 
Proportions of participants with attention domain scores at least one standard deviation 
below the mean for the CKD versus control groups. 
 CKD  Control 
Focus/Execute 5/30 (17%)  3/41 (7%) 
Sustain   9/30 (30%)  6/41 (15%) 
Stability 10/30 (33%)  8/41 (20%) 
Shift* 10/30 (33%)  3/41 (7%) 
Encode** 13/30 (43%)  4/41 (10%) 
Notes. *p < .05; **p < .01; ***p < .001 
Question 3 
What functional- (e.g., recent school absences, IQ), family- (e.g., SES), and 
disease-related (e.g., disease severity, age of onset, duration of disease) variables 
predict attention domain scores?  It was hypothesized that lower IQ scores, higher 
numbers of school absences, lower SES, earlier age of CKD onset, longer duration of 
CKD, lower eGFR calculations, and co-morbid diagnoses of anemia or hypertension 
would be associated with lower scores on all attention domains (Focus/Execute, Sustain, 
Stability, Shift, Encode).  It was also hypothesized that IQ scores, SES, and CKD severity 
(eGFR) would be significant predictors of all five attention domains within the proposed 
model of attention. 
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Correlations were derived among the attention outcome measures and the 
variables selected a priori (i.e., recent school absences, IQ, maternal education, disease 
severity, age of onset, duration of disease, comorbid diagnoses; Table 6).  For all five of 
the attention domains (Focus/Execute, Sustain, Stability, Shift, Encode), three variables 
were significantly correlated, including WASI Full Scale IQ, SES, and eGFR (i.e., CKD 
severity).  Recent school absences were negatively correlated with the Sustain and 
Stability domains. Age of CKD onset, duration of CKD, and having a comorbid diagnosis 
of anemia or hypertension were not significantly correlated with any attention domains.  
Variables that were correlated with the attention domains were then considered for 
inclusion in the regression equations.  A maximum of three variables were selected for 
entry into each regression equation in order to maintain a 10:1 case to variable ratio, 
given that the CKD group consisted of 30 participants. 
The three variables selected for the regression equations tapped the broad areas of 
general neurocognitive functioning (WASI Full Scale IQ), family characteristics (SES), 
and severity of disease (eGFR).  Due to the exploratory nature of these analyses and the 
small sample sizes used in these regression equations, the results of the overall regression 
equations were not interpreted.  Variables that predicted attention outcomes in the current 
CKD sample are discussed to provide future research with an initial model from which to 
work and test using larger data sets.  As shown in Table 7, results indicated that no 
predictor variables emerged as significant for the attention domains of Focus/Execute, 
Sustain, or Shift.  The regression equation for the Stability construct yielded the WASI 
Full Scale IQ as a significant predictor variable.  Similarly, the WASI Full Scale IQ 
emerged as a significant predictor of the Encode construct.
 Table 6. 
Correlations among attention domains and predictor variables. 
 
F
o
c
u
s
/
 
E
x
e
c
u
t
e
 
S
u
s
t
a
i
n
 
S
t
a
b
i
l
i
t
y
 
S
h
i
f
t
 
E
n
c
o
d
e
 
S
c
h
o
o
l
 
A
b
s
e
n
c
e
s
 
F
u
l
l
 
S
c
a
l
e
 
I
Q
 
S
E
S
 
e
G
F
R
 
A
g
e
 
o
f
 
O
n
s
e
t
 
D
u
r
a
t
i
o
n
 
o
f
 
C
K
D
 
H
y
p
e
r
t
e
n
s
i
o
n
 
A
n
e
m
i
a
 
Focus/Execute 1             
Sustain 0.59** 1            
Stability 0.50** 0.71** 1           
Shift 0.40** 0.10 0.17 1          
Encode 0.48** 0.48** 0.37** 0.47** 1         
School Absences -0.19 -0.30* -0.35** -0.08 -0.10 1        
Full Scale IQ 0.45** 0.38** 0.39** 0.28* 0.56** -0.29* 1       
SES 0.35** 0.29* 0.24* 0.26* 0.51** -0.07 0.60** 1      
eGFR 0.39** 0.36** 0.33** 0.24* 0.51** -0.49** 0.74** 0.53** 1     
Age of Onset 0.27 0.09 -0.15 0.19 0.30 0.30 0.04 0.30 -0.07 1    
Duration of CKD -0.30 -0.16 -0.03 -0.24 -0.36 -0.23 -0.32 -0.45* -0.25 -0.76** 1   
Hypertension -0.05 0.21 -0.11 -0.12 0.03 0.24 0.05 -0.11 -0.10 0.03 0.01 1  
Anemia -0.01 -0.34 -0.23 0.04 -0.20 -0.18 0.17 -0.03 -0.02 -0.04 0.15 -0.02 1 
Notes: *p < .01; **p < .001
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Table 7. 
Regression equation coefficients by attention domain. 
Attention Domain Predictor Variables Beta t Significance 
Focus/Execute WASI Full Scale IQ .351 1.523 .140 
 eGFR (CKD Severity) .226 1.080 .290 
 SES .105 .575 .570 
Sustain WASI Full Scale IQ .388 1.571 .128 
 eGFR (CKD Severity) .097 .430 .671 
 SES .057 .291 .773 
Stability WASI Full Scale IQ* .556 2.256 .033 
 eGFR (CKD Severity) -.079 -.355 .726 
 SES -.038 -.196 .846 
Shift WASI Full Scale IQ -.025 -.092 .928 
 eGFR (CKD Severity) .184 .740 .466 
 SES .138 .636 .530 
Encode WASI Full Scale IQ* .497 2.053 .048 
 eGFR (CKD Severity) .092 .409 .686 
 SES .049 .247 .807 
Notes: * p < .05 
Additional Exploratory Analyses 
 Once the data analyses were conducted to address the research questions and 
associated hypotheses, several additional exploratory data analyses were executed to 
determine the presence of any trends in the data that could assist with hypothesis testing 
for a larger study sample.  As such, the CKD group was subdivided into two groups, the 
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Mild/Moderate CKD group and the End-Stage Renal Disease (ESRD) group, to 
determine the effect of disease severity, or lack thereof, accounting for the CKD versus 
control group differences reported above. 
 Preliminary data analyses on the WASI Full Scale IQ scores indicated that the 
Mild/Moderate CKD group (M = 100.00, SD = 13.02) differed significantly from the 
ESRD group (M = 81.40, SD = 12.20), F(1, 28) = 16.31, p < .001.  The WASI Full Scale 
IQ was therefore used as a covariate on the subsequent ANCOVA analyses.  Visual 
analysis of the descriptive statistics indicated a trend in the data for poorer performance 
by the ESRD group in several domains (Table 8).  However, due to the small sample 
sizes and high correlations between the WASI Full Scale IQ and each of the attention 
domains, the Mild/Moderate CKD and ESRD groups could not be adequately compared 
on the attention domains using the WASI Full Scale IQ as a covariate.   
Table 8. 
Attention by group (Mild/Moderate CKD, n = 15; ESRD, n = 15) and domain. 
 ESRD  Mild/Moderate CKD 
 M SD  M SD F-Tests Effect Size 
Focus/Execute** 88.32 12.33  101.01 5.70 13.08 1.32 
Sustain* 87.19 18.56  101.54 9.55 7.09 0.97 
Stability* 78.84 19.89  95.41 12.43 7.49 0.99 
Shift 90.22 12.79  92.78 9.19 0.40 0.23 
Encode* 85.33 10.56  92.50 6.48 5.02 0.82 
Notes. *p < .05; **p < .01; ***p < .001; Effect size presented as Cohen’s d. 
Exploratory univariate analyses of variance (ANOVAs) were then performed to 
determine if a trend existed in the data suggesting that the Mild/Moderate CKD and 
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ESRD groups differed from one another on the five attention domains.  Results from the 
univariate procedures indicated that the Mild/Moderate CKD group differed from the 
ESRD group on the Focus/Execute, F(1, 28) = 13.08, p = .001, d = 1.32; Sustain, F(1, 28) 
= 7.093, p = .02, d = 0.97; Stability, F(1, 28) = 7.49, p = .01, d = 0.99; and the Encode 
domains, F(1, 28) = 5.021, p = .03, d = 0.82.   The Mild/Moderate CKD and ESRD 
groups did not differ significantly with respect to group comparisons on the Shift (p = 
.53, d = 0.23) domain. 
To obtain a better understanding of the Mild/Moderate CKD and ESRD data, chi-
square analyses were conducted to examine the proportion of children in each group who 
evidenced significant attentional impairment one standard deviation or more below the 
mean.  Results from the chi-square analyses revealed that the Mild/Moderate CKD and 
ESRD groups differed significantly with respect to the proportion of children 
demonstrating significant problems on the Focus/Execute domain, χ2 (1, n = 30) = 6.00, p 
= .01; the Sustain domain, χ2 (1, n = 30) = 7.78, p = .005; and the Stability domain, χ2 (1, 
n = 30) = 5.40, p = .02.  Results approached significance for the Encode domain, χ2 (1, n 
= 30) = 3.39, p = .065.  The Mild/Moderate CKD and ESRD groups did not differ with 
respect to the proportion of cases evidencing attention dysfunction on the Shift domain, 
χ
2
 (1, n = 30) = 0.00, p = 1.000 (Table 9). 
Results from each of these exploratory analyses are to be interpreted with extreme 
caution and cannot be generalized beyond the current sample.  Small sample size and 
lack of adequate statistical power prevent any such interpretation to be made.  However, 
these findings may provide some preliminary evidence for the effect of disease severity 
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on attention in children with CKD.  These factors related to disease severity should be 
considered by researchers when planning future studies. 
Table 9. 
Proportions of attention domain scores at least one standard deviation below the mean 
for the Mild/Moderate CKD versus ESRD groups. 
 Mild/Moderate CKD  ESRD 
Focus/Execute* 0/15 (0%)  5/15 (33%) 
Sustain** 1/15 (7%)  8/15 (53%) 
Stability* 2/15 (13%)  8/15 (53%) 
Shift 5/15 (33%)  5/15 (33%) 
Encode 4/15 (27%)  9/15 (60%) 
Notes: * p < .05, ** p < .01 
 
 CHAPTER V 
DISCUSSION 
 The current study examined whether children with chronic kidney disease (CKD) 
demonstrated impairments in specific domains of their attention functioning relative to a 
group of their typically-developing peers.  Attention is arguably one of the most vital 
neurocognitive functions of childhood in that it factors into a child’s ability to acquire, 
understand, and retain learned information in social and educational environments.  
Because of this importance, attentional dysfunction could predispose a child to 
difficulties in other areas as well, including his or her academic performance or 
interpersonal relatedness.  Due to the fact that children with CKD evidence executive 
function deficits (Gipson et al., 2006), an in-depth understanding of the effects of 
pediatric CKD on the integrity of attention processes was warranted. 
 The current literature on neurocognitive outcomes for school-age children with 
CKD suggests a number of findings indicative of cognitive dysfunction.  A number of 
these studies have collectively revealed a trend for some generalized deficits in cognition 
(Bawden et al., 2004; Brouhard et al., 2000; Lawry et al., 1994; Mendley & Zelko, 1999; 
Qvist et al., 2002). Interpreting the available findings related to specific neurocognitive 
functions in children with CKD has been problematic due to the significant 
improvements made in medical and pharmacological interventions (Gorman, 1995; 
Grantham-McGregor, 1995; Halterman et al., 2001; Lande et al., 2003; Marsh et al., 
1991; NKF, 2002).  However, the consensus among contemporary studies examining 
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memory and executive functions in pediatric CKD is that these neurodevelopmental 
abilities should be monitored over time for any possible deficits (Fennell et al., 1990; 
Gipson et al., 2006; Mendley & Zelko, 1999; Qvist et al., 2002).  Taking the literature on 
attention in adults with CKD also into consideration (Yount et al., 1998), there is 
sufficient evidence to suggest the possibility of specific weaknesses in aspects of 
attention for children with CKD. 
 Although previous research has examined general and specific neurocognitive 
functions in pediatric patients with CKD, no known research has targeted specific 
domains of attention in children with CKD.  The current study attempted to address this 
gap in the extant literature by comparing the performance of children with CKD on five 
attention domains to that of a comparison group comprised of typically-developing 
children.  Strengths related to this study include use of an empirically supported model of 
attention and a study design using a case-control comparison, which assists in drawing 
conclusions about the effects of CKD on attention outcomes outside of the influence of 
demographic factors.  Multiple measures of attention also were used to construct the 
attention domains.  The text below discusses the results of the current study by examining 
the obtained results with the hypotheses established a priori.  Possible explanations for 
the results, limitations of this study, and potential areas for future research follow. 
Question 1 
 Do specific domains of attention in children and adolescents with CKD differ 
significantly from those measured in typically-developing children and adolescents?  
It was hypothesized that children with CKD would be at increased risk for attention 
problems when compared to a matched control group.  Specifically, it was expected that 
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the performance of children with CKD would be lower than the control group in the 
following attention domains: Focus/Execute, Sustain, and Encode.  It was also 
hypothesized that the CKD group would exhibit similar performance to the control group 
on the Stability and Shift attention domains. 
 The proposed hypotheses were partially supported by the obtained results.  Group 
differences were obtained on the MANCOVA analysis, and follow-up univariate 
procedures indicated that the control group differed significantly from the CKD group on 
several attention domains.  Specifically, the control group obtained significantly higher 
scores than the CKD group, even after controlling for differences in IQ and age, on the 
Focus/Execute, Sustain, Stability and Encode attention domains.  No significant group 
differences were evident on univariate follow-up procedures with regards to Shift 
attention domain. 
Question 2 
 Do pediatric patients with CKD differ significantly from typically-developing 
children in their observed proportion of attention problems?  Specifically, does a 
higher proportion of pediatric patients with CKD evidence difficulties with attention one 
standard deviation or more below the mean (i.e., SS < 85)?  It was hypothesized that a 
higher proportion of children in the CKD group would demonstrate attention problems 
(SS < 85) relative to the control group within several specific attention domains 
(Focus/Execute, Sustain, and Encode).  It was also hypothesized that children in the CKD 
group would demonstrate similar proportions of problems on the Stability and Shift 
attention domains. 
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 In order to rule out the potential effects of individual participants’ scores 
confounding the group comparisons in research question #1, the proportion of children 
who scored one standard deviation or more below the mean on each attention domain was 
compared by group.  The obtained findings again partially supported the proposed 
hypothesis, as results indicated that the CKD and control groups differed with respect to 
the proportion of participants who fell one standard deviation or more below the mean on 
the Shift and Encode attention domains.  The range of participants in the CKD group 
falling one standard deviation or more below the mean on attention domains (17% on 
Focus/Execute, 43% on Encode; Table 5) was similar in frequency to findings in at least 
one previous study (Qvist et al., 2002) in which the prevalence of generalized attention 
deficits was estimated to be approximately one-fourth of the study sample. 
Additional Exploratory Analyses for Questions 1 & 2 
 The division of the CKD group into the Mild/Moderate CKD and ESRD groups 
allowed for comparisons across disease severity groups.  Children in the ESRD group 
were found to have significantly lower IQ scores than the Mild/Moderate CKD group.  
Univariate comparisons of the two groups on attention domains without using IQ as a 
covariate indicated that the two groups differed significantly on the Focus/Execute, 
Sustain, Stability, and Encode attention domains (Table 8).  Children across these two 
severity groups also differed in the proportions of clinically significant attention 
problems on the Focus/Execute, Sustain, and Stability domains, with the ESRD group 
having a higher proportion showing evidence of attention dysfunction (Table 9).  The 
implications for these findings suggest that children with the most severe levels of CKD 
(i.e., kidney failure, ESRD) should be monitored closely in their overall neurocognitive 
 78 
development, certainly with regard to their generalized intelligence and perhaps also with 
regards to specific neurocognitive functions such as attention skills. 
Interpretation for Questions 1 & 2 
 Results from the current study provide some of the most comprehensive findings 
to date on the attention functioning of children with CKD.  Although based on a 
relatively small sample, the obtained results further illustrate the emerging concerns 
related to the integrity of generalized and specific neurocognitive dysfunction for 
children with CKD.  This study demonstrated lower performance within several specific 
domains of attention, including focused/timed concentration, sustained attention, stability 
of attention across time, and poorer encoding of information retrieved through attention 
processes, for children with CKD relative to typically-developing peers.  These findings 
were present while controlling for the generalized effects of age and intelligence.  In this 
regard, these findings are consistent with the available literature suggesting the presence 
of subtle cognitive deficits in children with CKD (Gipson et al., 2006; Hart et al., 1983; 
Qvist et al., 2002; Slickers et al., 2007). 
 It is important to consider that while the CKD differed significantly with respect 
to performance on the four attention domains mentioned above, children in the CKD 
group performed generally within the average range as a group.  Additionally, in contrast 
to the slight downward shift in specific domains of attention (e.g., Focus/Execute, 
Sustain, Stability, and Encode) in the current study, the CKD group did not differ from 
the control group with regard to shifting from one salient aspect of a stimulus to another 
(Shift).  This finding suggests a possible functional strength for children with CKD with 
respect to these brain-based functions, particularly with respect to frontal lobe integrity.  
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Keeping in line with previous research suggesting limited to no group differences and 
mostly intact functioning related to attention (Fennell et al., 1990a, 1990b; Mendley & 
Zelko, 1999; Qvist et al., 2002), this finding on the Shift domain suggests that numerous 
factors related to CKD could affect performance on attention-related tasks.  Previous 
findings on memory, executive functions, and clinical predictors of neurocognitive 
dysfunction with this same sample are consistent with the obtained results on shifting and 
sustained attention, lending additional support to this finding (Gipson et al., 2006; 
Slickers et al., 2007). 
Several explanations are possible for the findings related to attention domains as 
well as the proportion of attention dysfunction for these first two research questions.  
First, the main explanation for the obtained findings could be related to measurement 
questions.  It is quite possible that attention outcomes related to CKD during childhood 
were extremely difficult to measure in this sample due to the evolution of frontal lobe 
functioning occurring during the school-age and pre-teen years.  Since the mean age for 
the CKD sample was approximately 12-13 years of age (Table 2), the process of 
identifying attention problems through direct measurement could have been problematic 
given the varying trajectories of frontal lobe development at these wide age ranges.  As 
such, the effects of CKD on attention may lie dormant until the teenage years when 
adolescents are presented with tasks and experiences in high school requiring 
sophisticated attention and executive functioning.  Although significant differences were 
obtained when chronological age was controlled for in the current study, it will be 
necessary to replicate these findings with a more targeted age range of participants in 
order to generalize the findings.  In this sense, extraneous factors such as task demands as 
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a function of developmental stage, treatment adherence, later effects of CKD, and small 
sample sizes are important considerations to make when interpreting the obtained 
differences for these specific attention domains. 
Another possible explanation for group differences in specific attention domains 
could be due to morbidity effects related to CKD severity.  In this regard, it is within 
reason that children presenting to their pediatric nephrologist with the most severe levels 
of CKD (i.e., kidney failure; ESRD) may be more urgent candidates for a kidney 
transplant.  Additionally, previous research has shown that children with CKD can 
experience improvements in specific neurocognitive functions, including attention, 
following a kidney transplant (Mendley & Zelko, 1999).  Because this study focused only 
on children and adolescents with CKD who had not previously undergone a kidney 
transplant, the remaining patient sample from the current study could potentially 
represent a subset of CKD patients with adequate medical and neurocognitive outcomes 
at the time of study participation.  Similarly, patients who required kidney transplants 
prior to participation in this study could also potentially represent a contrasting subset of 
CKD patients that experience a higher incidence of neurocognitive dysfunction, but were 
not included in this study.  Therefore, a large-scale study that can capture a large 
proportion of pediatric patients with CKD may capture more generalized attention 
problems due to the potential morbidity effects. 
An additional explanation related to morbidity is that children with kidney failure 
(ESRD) in this study may have been monitored more closely because of the severity of 
their illness.  By this line of thinking, the extent of CKD severity may have alerted the 
pediatric nephrologists responsible for these children’s medical care to discuss the 
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potential risks for neurodevelopmental deficits with parents and teachers.  Although this 
is merely speculation, any extra intervention not accounted for in the study design, such 
as special education services, could have mediated outcomes related to attention in this 
study.  Analyzing physician notes related to informal clinical monitoring of 
neurocognitive development could provide additional insight into this potential 
explanation. 
Regarding the inconsistency in group differences for the proportion of attention 
dysfunction by group, one possible explanation could be that children with CKD 
evidence differential impairments in their attention across the age range.  This suggests 
that specific attention impairments could emerge at different time points for each child, 
particularly when academic task demands increase and students are increasingly 
responsible for independently maintaining attention to preserve their own success in the 
classroom.  In addition, children with CKD may receive more monitoring and educational 
supports as part of their medical care, in an effort to intervene with attention problems 
when they first emerge.  This explanation would provide much positive support for 
early/preventive intervention services following the diagnosis of CKD. 
The issue of treatment adherence is also of importance when discussing attention 
in children with CKD.  However, data related to adherence to medical and 
pharmacological regimens were not available for analysis with this sample.  Previous 
literature has discussed the pathophysiological mechanism by which CKD leads to 
progressive waste product accumulation in the body, which precedes uremia-induced 
cognitive difficulties (Gipson et al., 2004).  Therefore, the issue of adherence seems to be 
a potentially confounding variable that could warrant further investigation in future 
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studies.  Although the use of a typically-developing control group allowed for 
comparison between the CKD group and their demographically-matched peers, it is 
potentially feasible that children with complicated forms of CKD could have more erratic 
patterns of adherence, due in part to the complicated nature of their treatment (i.e., 
dialysis, medications, dietary restrictions) regimens.  The ability to accurately detect 
difficulties with treatment adherence through laboratory findings would be necessary to 
monitor the association with specific neurocognitive problems.  Serial assessments with 
in-depth analysis of laboratory findings beginning at CKD diagnosis could also provide a 
better analysis of neurocognitive functioning as a byproduct of adherence longitudinally. 
An additional explanation for the inconsistent findings across attention domains in 
this study deals with the relatively small sample size afforded by studying such a specific 
chronic illness of childhood.  The ability to recruit a larger sample through a multi-site 
study could produce stronger findings with greater statistical power.  Furthermore, a 
larger sample could allow for in-depth analysis of children with CKD by disease severity 
group with the use of a comparison group (i.e., Mild/Moderate CKD vs. ESRD vs. 
Control groups) that could potentially reveal other subtle differences in the data. 
In general, these findings suggest that the presence of CKD during childhood may 
result in subtle, specific deficits in certain domains of attention.  Results indicated that 
these weaknesses in specific domains of attention were disproportionate for children with 
CKD, and were evident above and beyond the contribution of general intelligence.  
However, a number of other factors, including disease severity, treatment adherence, task 
demands by age, and previous intervention and available supports may play a significant 
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contributing role in determining whether attention deficits are manifested for a child with 
CKD. 
Question 3 
 What functional- (e.g., recent school absences, IQ), family- (e.g., SES), and 
disease-related (e.g., disease severity, age of onset, duration of disease) variables 
predict attention domain scores?  It was hypothesized that lower IQ scores, higher 
numbers of school absences, lower SES, earlier age of CKD onset, longer duration of 
CKD, lower eGFR calculations, and co-morbid diagnoses of anemia or hypertension 
would be associated with lower scores on all attention domains (Focus/Execute, Sustain, 
Stability, Shift, Encode).  It was also hypothesized that IQ scores, SES, and CKD severity 
(eGFR) would be significant predictors of all five attention domains within the proposed 
model of attention. 
Interpretation for Question 3 
 Although the small sample size for this study ruled out any broad generalizations 
related to the findings in research question #3, this portion of the current study attempted 
to determine whether variables could preliminarily predict attention outcomes for 
children with CKD.  The development of such a model to predict attention outcomes in 
school-age children with CKD could provide pediatric nephrologists with a means of 
identifying children at risk for this specific neurocognitive deficit. 
 The general trend in the data was for small-to-moderate positive correlations to 
exist among several predictor variables (WASI Full Scale IQ, SES, eGFR scores) and 
attention domains (Focus/Execute, Sustain, Stability, Shift, and Encode).  This data 
suggested that higher scores on these attention domains were related to higher IQ scores, 
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higher levels of SES, and higher filtration levels in the kidneys (i.e., lower CKD 
severity).  These three variables reflected the broad categories of child characteristics 
(IQ), family characteristics (maternal education), and disease characteristics (CKD 
severity).  Moderate negative associations were also evident between the number of 
recent school absences and the Sustain and Stability attention domains, indicating that 
fewer school absences were associated with higher scores on these attention domains.  It 
was interesting to note that age of CKD onset and duration of CKD were not found to be 
associated with any of the attention domains. 
 Results from the regression equations showed WASI Full Scale IQ score to be a 
significant predictor of the Stability and Encode attention domains.  WASI Full Scale IQ 
was also found to approach significance with respect to predicting scores on the 
Focus/Execute and Sustain domains.  However, no other variables were significant 
predictors of the attention domains. 
 The findings from this study were in slight contrast to the findings with this 
sample by Slickers and colleagues (2007), in which no associations were evident between 
clinical predictor variables and generalized attention data from the Gordon Diagnostic 
System.  From a face validity perspective, it was surprising that CKD severity was not a 
significant predictor for any of the attention domains, particularly given previous findings 
indicating CKD severity to be significantly associated with IQ and memory scores 
(Slickers et al., 2007).  The lack of predictive value for age of CKD onset and duration of 
CKD on attention domains was also surprising, although this lack of association may 
reflect the tendency for patients to present initially to their pediatric nephrologist with 
already severe disease (Slickers et al., 2007).  As has been suggested by other researchers 
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(Slickers et al., 2007), this situation would make the date of CKD onset less reflective of 
the point at which reduced renal function actually occurred, thereby reducing the 
predictive value of these variables.  Nonetheless, the current findings represent the first of 
its kind with respect to clinical predictors of specific attention domains with a sample of 
pediatric patients with CKD. 
 Overall, the obtained data were among the first to date that focused on identifying 
potential risk factors for attention dysfunction in children with CKD.  Future research 
must examine potential predictors of attentional dysfunction more carefully so as to assist 
in creating a model of cumulative risk.  Perhaps larger sample sizes can help to better 
parse out predictor variables with respect to the impact of attention functioning. 
Limitations 
Although the current study provided contemporary findings on subject matter that 
has not received adequate attention in the extant literature, certain limitations inherent to 
this study exist and are discussed as follows in an effort to guide future research.  First 
and foremost, the small sample size for the CKD group was to be expected given the 
specificity of inclusion/exclusion criteria for a chronic illness of childhood.  As such, the 
number of CKD group participants (n = 30) precluded any broad generalizations from the 
data and limited the amount of within-group analysis that could occur.  Additionally, the 
matching of demographic variables for the comparison group ideally would have been 
more accurate.  Although the CKD and control groups did not differ with respect to 
chronological age, gender, or race, the variables of child IQ and SES differed 
significantly between groups.  Future research could address this limitation and better 
match the groups through several recruiting methods, including the use of sibling-
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matched controls, the collection of more detailed information gathering during 
recruitment to ensure proper matching, and/or increased recruitment in low- and middle-
class neighborhoods. 
From a measurement perspective, several specific issues were also evident in the 
current study.  First, as discussed previously in the introduction, parsing apart attention 
from executive functions and memory is difficult from both theoretical and data-
gathering perspectives.  The degree of overlap among these three constructs is debatable, 
but undoubtedly present to a certain degree.  Additionally, the age at which the majority 
of participants were enrolled in the study corresponds with the time frame for 
developmental trajectories of frontal lobe impairments.  Therefore, the previously 
discussed factor of task demands by age is another limitation that could have precluded 
finding more severe or quantitatively more group differences on attention domains.  With 
regards to research design, this study examines each child’s performance at baseline – 
one data point – and therefore cannot account for situational/environmental factors that 
could have hindered or enhanced a child’s performance on the day of study participation.  
Furthermore, longitudinal tracking of attention outcomes over time in these participants is 
also difficult given that many of the instruments used were designed for use with school-
age children only. 
Future Research 
The current study examined a topic that has gone largely unaddressed in the area 
of CKD research.  Current findings suggest that certain aspects of attention may be 
vulnerable to the presence of CKD during childhood, with factors such as general 
intelligence and disease severity potentially impacting the degree of attentional 
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impairment.  These results also suggest that CKD may not global deficit in attention, 
although additional research is required to confirm these findings and deal with the 
limitations of the current study.  Future research should set out to establish large sample 
sizes through multi-site or multi-center collaboration in order to allow for more extensive 
analysis of predictor variables through regression equations.  This process would allow 
for the development of a predictive model of attentional outcomes in children with CKD, 
giving pediatric nephrologists a valuable tool to guide collaborative care and better 
monitor the neurocognitive needs of this population.  Future research would also benefit 
from gathering extensive information regarding the available services and 
educational/social supports in the child’s community, so as to learn more about the 
formal and informal interventions that could potentially mediate outcomes.  Additionally, 
the use of attention-specific parent and teacher questionnaires would also be helpful in 
providing reliable observations of the child’s typical attention functioning on a daily basis 
in different settings (i.e., home and school).  Longitudinal follow-up could also provide a 
better perspective of the development of attentional impairments over time as the task 
demands of middle and high school bring subtle neurocognitive deficits to the 
observation of parents and teachers. 
Future research should also focus on the intervention needs for children with 
CKD with regard to educational supports and the role taken on by psychologists and/or 
educational support staff.  In this regard, researchers should attempt to clarify the 
question of function versus etiology in this population with regards to attention.  By 
doing so, it will provide parent, teachers, and professionals with specific information on 
the reason these children need intervention, as well as the target of said interventions.  
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Psychologists will likely play the role of assessor through periodic monitoring via 
neuropsychological assessments, and may also play the valuable role of conveying 
developmental expectations relative to the neurocognitive functioning of the child with 
CKD. 
With regards to classification in the schools, future research should also weigh the 
positive and negative aspects of providing educational support services to children with 
CKD broadly under a general medical heading (e.g., Other Health Impaired – OHI), with 
a secondary classification for any cases of specific neurocognitive deficits (e.g., LD for 
specific academic delays).  This consideration could help parents and teachers to better 
document their child’s educational and social-emotional needs at school.  This 
consideration for multiple special education classifications could also facilitate serving 
each child’s unique educational needs related to extended periods of absenteeism for 
medical visits, fatigue related to chronic illness, and emerging psychoeducational deficits 
secondary to CKD progression.  In this sense, this pursuit could potentially provide an 
interventional and classification framework aimed at providing the most appropriate 
services to children with CKD.  This process could also produce the secondary benefit of 
educating teachers and staff as to the specific areas of cognitive difficulty and the nature 
and nuances of CKD. 
Conclusions 
 Children with CKD can potentially evidence a variety of general and specific 
neurocognitive deficits.  Due to a lack of findings on this topic in the available literature, 
the current study compared the attention functioning of school-age children with CKD to 
a group of typically-developing controls.  Significant differences on group means were 
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revealed between the CKD (n = 30) and control (n = 41) groups on the Stability and 
Encode attention constructs.  No other group differences emerged on the Focus/Execute, 
Sustain, and Shift attention constructs.  The CKD and control groups did not differ with 
respect to the observed incidence of significant attentional dysfunction.  Exploratory 
analyses with a subdivided CKD group suggested that the end-stage renal disease (ESRD, 
i.e., kidney failure) group had a higher incidence of significant attentional impairments 
on the Stability and Encode attention constructs.  IQ scores and maternal education were 
found to be positively correlated to a moderate degree with attention outcomes, while 
disease severity and recent school absences were negatively correlated to a moderate 
degree with attention outcomes.  Additionally, IQ scores were a significant predictor of 
the Stability and Encode attention constructs.  No predictors emerged for the 
Focus/Execute, Sustain, or Shift attention constructs. 
 Taken together, the results of this study implicate subtle and specific attentional 
dysfunctions, particularly in stability of attention over time and encoding of information, 
for children with CKD.  As a whole, these findings may suggest a chronic vulnerability 
of higher-order neurocognitive functions in children and adolescents with CKD.  This 
raises questions regarding the integrity of the structure and function of frontal and 
prefrontal brain regions in the pediatric CKD population, with specific concerns for 
neurodevelopmental insults associated with disease severity, the age of onset, and/or the 
duration of kidney disease.  These findings also raise questions regarding how and when 
neurodevelopmental trajectories of targeted brain regions may be affected, and suggest 
that these brain regions may be vulnerable to the effects of uremia and the accumulation 
of waste products that are associated with CKD. 
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 In sum, the current findings should assist in beginning to target attention for 
neurodevelopmental surveillance within this population.  It will also be critical for 
children with CKD to receive close developmental surveillance and monitoring of these 
functions.  Through long-term, systematic follow-up, the issue of attention functioning in 
CKD may be addressed in reference to the timeliness, type, and response to various 
individualized interventions for these children.
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